Processing 00000000.tx.1: Haplotypes extending across ACE are associated with Alzheimer's disease Patrick G. 

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "extending across ACE"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   882   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   790   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439792:Extending [Spatial Concept]
   719 E C0231448:Extend [Functional Concept]

Phrase: "are"

Phrase: "associated with Alzheimer's disease Patrick G."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0243083:associated disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0439267:g% [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.2: Kehoe1, Hagit Katzov2, Lars Feuk2, Anna M. 

Phrase: "Kehoe1,"

Phrase: "Hagit Katzov2,"

Phrase: "Lars Feuk2,"

Phrase: "Anna M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Bennet3, Boo Johansson4, Bjrn Wiman5, Ulf de Faire3,6, Nigel J. 

Phrase: "Bennet3,"

Phrase: "Boo Johansson4,"

Phrase: "Bjrn Wiman5,"

Phrase: "Ulf de Faire3,"

Phrase: "6,"

Phrase: "Nigel J."
Processing 00000000.tx.4: Cairns7, Gordon K. 

Phrase: "Cairns7,"

Phrase: "Gordon K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.5: Wilcock1, Anthony J. 

Phrase: "Wilcock1,"

Phrase: "Anthony J."
Processing 00000000.tx.6: Brookes2, Kaj Blennow8 and Jonathan A. 

Phrase: "Brookes2,"

Phrase: "Kaj Blennow8"

Phrase: "and"

Phrase: "Jonathan A."
Processing 00000000.tx.7: Prince2,* 1Department of Care of the Elderly, University of Bristol, The John James Building, Frenchay Hospital, Bristol, UK, 2Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden, 3Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden, 4Department of Psychology, University of Gteborg, Gteborg, Sweden, 5Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden, 6Department of Cardiology, Karolinska Hospital, Stockholm, Sweden, 7Department of Neuropathology, Institute of Psychiatry, King's College, London, UK and 8Department of Clinical Neuroscience and Transfusion Medicine, University of Gteborg, Sahlgren's University Hospital, Sweden Received December 12, 2002; 

Phrase: "Prince2,"

Phrase: "* 1Department of Care of the Elderly,"

Phrase: "University of Bristol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "The John James Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]

Phrase: "Frenchay Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Bristol,"

Phrase: "UK,"

Phrase: "2Center for Genomics"

Phrase: "and"

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "3Division of Cardiovascular Epidemiology,"

Phrase: "Institute of Environmental Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0021621:Institute of Medicine [Health Care Related Organization]
           institute medicine
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "4Department of Psychology,"

Phrase: "University of Gteborg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Gteborg,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "5Department of Clinical Chemistry,"

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "6Department of Cardiology,"

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "7Department of Neuropathology,"

Phrase: "Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "King's College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: "and"

Phrase: "8Department of Clinical Neuroscience"

Phrase: "and"

Phrase: "Transfusion Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1273858:Transfusion Medicine [Biomedical Occupation or Discipline]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Gteborg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Sahlgren's University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Sweden Received December 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038995:Sweden [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.8: Accepted February 7, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Numerous genes have been implicated in Alzheimer's disease (AD), but, with the exception of a demonstrated association with the 4 allele of APOE, findings have not been consistently replicated across populations. 

Phrase: "Accepted February 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Numerous genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: ","

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of a demonstrated association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "with the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "of APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "consistently"

Phrase: "replicated across populations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032659:Population [Quantitative Concept]
   790   C0205173:replicated [Functional Concept]
   790   C1257890:Population [Population Group]
   756 E C0205341:Replicate [Functional Concept]
   756 E C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.9: One of the most widely studied is the gene for angiotensin I converting enzyme (ACE). 

Phrase: "One of the most widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the gene for angiotensin I converting enzyme (ACE)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1333402:Enzyme Gene [Gene or Genome]
   774   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   748   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.10: A meta-analysis of published data on a common Alu indel polymorphism in ACE was performed which indicated highly significant association of the insertion allele with AD (OR 1.30; 95% CI 1.191.41; P=4x10-8). 

Phrase: "A meta-analysis of published data"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   783   C0010992:Data Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "on a common Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "which"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "highly significant association of the insertion allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with AD ("

Phrase: "OR"

Phrase: "1.30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.191.41"

Phrase: "; P=4x10-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.11: To further explore the influence of ACE on AD, several single-nucleotide polymorphisms (SNPs) were genotyped in five independent populations represented by over 3100 individuals. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "explore"

Phrase: "the influence of ACE"

Phrase: "on AD,"

Phrase: "several single-nucleotide polymorphisms (SNPs)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped in five independent populations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0032659:Population [Quantitative Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C0205451:Five [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1299583:Independent [Finding]
   726   C0017431:Genotype [Organism Attribute]

Phrase: "represented by over 3100 individuals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]
   726   C1882932:Represent [Activity]
Processing 00000000.tx.12: Analyses based upon single markers and haplotypes revealed strong evidence of association in casecontrol models and also in a model examining the influence of variation in ACE upon cerebrospinal fluid levels of amyloid 42 peptide (A42). 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "based upon single markers"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737   C0005516:Marker [Clinical Attribute]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "strong evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in casecontrol models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "also in a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the influence of variation"

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "upon cerebrospinal fluid levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007806:Cerebrospinal Fluid [Body Substance]
   901   C0007807:cerebrospinal fluid [Functional Concept]
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of amyloid 42 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(A42"

Phrase: ")."
Processing 00000000.tx.13: The most significant evidence for association with AD was found for an SNP, A-262T, located in the ACE promoter (OR 1.64; 95% CI 1.331.94; P=2x10-5). 

Phrase: "The most significant evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "with AD"

Phrase: "was"

Phrase: "found for an SNP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0752046:SNP [Nucleotide Sequence]
   770   C1527094:SNP [Conceptual Entity]
   737 E C0243095:Find [Finding]

Phrase: "A-262T,"

Phrase: "located in the ACE promoter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: "OR"

Phrase: "1.64"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.331.94"

Phrase: "; P=2x10-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.14: Estimates of population attributable risk for the common allele of this SNP suggest that it, or an allele in tight linkage disequilibrium (LD) with it, may contribute to as much as 35% of AD in the general population. 

Phrase: "Estimates of population attributable risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1519101:Risk Estimate [Quantitative Concept]
   760   C0750572:estimates [Quantitative Concept]

Phrase: "for the common allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "of this SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it,"

Phrase: "or"

Phrase: "an allele in tight linkage disequilibrium (LD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "with it,"

Phrase: "may"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "much as 35% of AD"

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.15: Results support a model whereby decreased ACE activity may influence AD susceptibility by a mechanism involving -amyloid metabolism.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a model whereby"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "ACE activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150225:angiotensin I-converting enzyme activity [Molecular Function]
   933   C2258685:angiotensin converting enzyme activity [Molecular Function]
   840   C0243102:enzyme activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "may"

Phrase: "influence"

Phrase: "AD susceptibility by a mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "involving -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "amyloid metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimer's disease (AD; MIM 104300) is a neurodegenerative disorder characterized by progressive memory loss and is the most common cause of dementia in the elderly. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: "; MIM 104300"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426941:MIM [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by progressive memory loss"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0002622:Memory loss [Mental or Behavioral Dysfunction]
   806   C0751295:Memory Loss [Sign or Symptom]
   760   C0025260:Memory [Mental Process]
   760   C0205329:Progressive [Functional Concept]
   760   C0700327:memory [Finding]
   760   C1517945:Loss [Quantitative Concept]
   760   C1706377:Memory [Manufactured Object]
   760   C1880022:Characterized [Activity]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "is"

Phrase: "the most common cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.17: Efforts to identify the genetic causes of certain rare familial forms of AD, representing a small fraction of all known AD cases, have been largely successful. 

Phrase: "Efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "identify"

Phrase: "the genetic causes of certain rare familial forms of AD,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0015127:causes [Functional Concept]
   739   C1314792:Causes [Functional Concept]
   706 E C1524003:Cause [Conceptual Entity]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "a small fraction of all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "largely successful."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1272703:Successful [Qualitative Concept]
   789 E C0597535:Success [Social Behavior]
Processing 00000000.tx.18: By the use of linkage mapping methods, mutations in the genes for amyloid precursor protein (APP), presenilin-1 (PSEN1) and presenilin-2 (PSEN2) have been found to underlie the majority of familial cases (13). 

Phrase: "By the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of linkage mapping methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "mutations in the genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "presenilin-1 (PSEN1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2 (PSEN2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underlie"

Phrase: "the majority of familial cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.19: However, for the more common form of AD, which probably results from a complex interplay between multiple genes and environmental factors, inheritance of the 4 allele of the APOE gene is the only genetic risk factor for which there is broad consensus (4). 

Phrase: "However,"

Phrase: "for the more common form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "of AD,"

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "results from a complex interplay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439855:Complex [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C2825142:Result [Finding]

Phrase: "between multiple genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "environmental factors,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "inheritance of the 4 allele of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0242538:Inheritance [Quantitative Concept]
   742   C0728826:Inheritance [Functional Concept]

Phrase: "is"

Phrase: "the only genetic risk factor for which there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0814299:factor genetic risk [Qualitative Concept]
   770   C0035648:Risk factor [Quantitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "broad consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376298:Consensus [Social Behavior]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.20: Over the last decade, genetic association studies have been used to suggest numerous genes as risk factors for AD (5), but most findings have never been replicated in independent materials. 

Phrase: "Over the last decade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "genetic association studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717878:Genetic Association Studies [Molecular Biology Research Technique]
   896   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1328885:genetic association [Occupation or Discipline]

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "numerous genes as risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "for AD (5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "most findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "been"

Phrase: "replicated in independent materials."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0085862:Independent [Idea or Concept]
   770   C0205173:replicated [Functional Concept]
   770   C0520510:Materials [Substance]
   770   C1299583:Independent [Finding]
   737 E C0205341:Replicate [Functional Concept]
   737 E C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.21: As a result of these difficulties in AD and in other phenotypes, the credibility of association methods for the identification of the genetic components of complex human traits has fallen under considerable scrutiny. 

Phrase: "As a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of these difficulties"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299586:difficulties [Finding]
   916 E C0332218:Difficult [Qualitative Concept]

Phrase: "in AD"

Phrase: "and in other phenotypes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0031437:Phenotypes [Organism Attribute]
   770   C1515981:And [Idea or Concept]
   737 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "the credibility of association methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0870373:credibility [Qualitative Concept]

Phrase: "for the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of the genetic components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "of complex human traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "has"

Phrase: "fallen under considerable scrutiny."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0085639:Fall [Finding]
   737   C0238715:Fall [Temporal Concept]
Processing 00000000.tx.22: Several papers have been written which illustrate the general difficulties to be expected using association methods (68). 

Phrase: "Several papers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030351:Papers [Manufactured Object]
   827 E C1547566:Paper [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "written"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0043266:write [Occupation or Discipline]
   966   C1576875:Write [Finding]
   966   C2584304:Write [Mental Process]

Phrase: "which"

Phrase: "illustrate"

Phrase: "the general difficulties to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1299586:difficulties [Finding]
   743 E C0332218:Difficult [Qualitative Concept]

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "association methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.23: Cited problems include inadequate statistical power, lack of correction for multiple testing, reliance upon markers which may be in weak linkage disequilibrium (LD) with functional risk variants, genetic heterogeneity, publication bias and potential genegene and/or geneenvironment interaction. 

Phrase: "Cited problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "inadequate statistical power,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0814897:Statistical Power [Research Activity]
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "lack of correction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "for multiple testing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]

Phrase: "reliance upon markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0290627:reliance [Biomedical or Dental Material]

Phrase: "which"

Phrase: "may"

Phrase: "be in weak linkage disequilibrium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0004093:Weak [Sign or Symptom]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C1762617:Weak [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "(LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ")"

Phrase: "with functional risk variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "genetic heterogeneity,"
Meta Candidates (Total=19; Excluded=15; Pruned=0; Remaining=4)
  1000   C0242960:Genetic Heterogeneity [Organism Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0019409:Heterogeneity [Qualitative Concept]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1512426:Heterogenous [Idea or Concept]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "publication bias"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "potential genegene"

Phrase: "and/or"

Phrase: "geneenvironment interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.24: For a handful of studies, the awareness of these and other issues has led to the conclusive identification of genetic risk factors in complex disorders such as type 2 diabetes (9), breast cancer (10) and Crohn's disease (11). 

Phrase: "For a handful"

Phrase: "of studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "the awareness of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004448:Awareness [Mental Process]

Phrase: "and"

Phrase: "other issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]

Phrase: "has"

Phrase: "led to the conclusive identification of genetic risk factors"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   790   C0814299:genetic risk factors [Qualitative Concept]
   784   C0812178:Genetic risk identification [Health Care Activity]
   764   C0035648:risk factors [Quantitative Concept]
   764   C1517512:Genetic Risk [Quantitative Concept]
   764   C1553898:risk factors [Idea or Concept]
   762   C0150323:Risk identification [Health Care Activity]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0020792:Identification [Mental Process]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205396:Identification [Qualitative Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C1708698:LED [Manufactured Object]
   742   C2828146:Conclusive [Qualitative Concept]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708   C1521761:Factor [Functional Concept]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708   C2827422:Factor [Conceptual Entity]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in complex disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "such as type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "breast cancer"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0006142:Breast Cancer [Neoplastic Process]
  1000   C0678222:Breast Cancer [Neoplastic Process]
   950 E C0153661:thoracic cancer [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "Crohn's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0010346:Crohn Disease [Disease or Syndrome]
           Crohn's
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.25: With respect to AD, the greater proportion of studies into putative risk genes has succumbed to many of these problems. 

Phrase: "With respect to AD,"

Phrase: "the greater proportion of studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "into putative risk genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "has"

Phrase: "succumbed to many of these problems."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1546466:Problems [Idea or Concept]
   719 E C0033213:Problem [Finding]
Processing 00000000.tx.26: Notably, most findings have not been replicated, few studies have employed high-powered population samples and, in the majority of cases, only single variants with unknown functional relevance have been assessed. 

Phrase: "Notably,"

Phrase: "most findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: ","

Phrase: "few"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "employed high-powered population samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "in the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "only single variants with unknown functional relevance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.27: In particular, studies focussing on single variants have ignored the potential for alternative polymorphisms to mediate susceptibility for disease where such effects may be better captured using haplotype-based methods (12,13). 

Phrase: "In particular, studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "focussing on single variants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0205419:variants [Qualitative Concept]
   737   C0205234:Focus [Spatial Concept]
   737   C1285542:focus [Functional Concept]

Phrase: "have"

Phrase: "ignored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554079:ignored [Idea or Concept]

Phrase: "the potential for alternative polymorphisms to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "susceptibility for disease where"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "such effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "captured"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "haplotype-based methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.28: Here, we provide evidence that variation in the gene for angiotensin I converting enzyme (ACE) contributes substantially to AD. 

Phrase: "Here,"

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that variation in the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "for angiotensin I converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "substantially to AD."
Processing 00000000.tx.29: Findings have been facilitated by meta-analysis of previously published studies on variants of ACE and AD, and by additional genotyping and haplotype analyses in several independent casecontrol populations.  

Phrase: "Findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "facilitated by meta-analysis of previously published studies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0034037:Published [Occupational Activity]
   744   C0936012:Analysis [Research Activity]
   744   C0947630:studies [Laboratory Procedure]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]
   744   C1704324:Published [Intellectual Product]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "on variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "of ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "AD,"

Phrase: "and by additional genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1524062:Additional [Functional Concept]

Phrase: "and"

Phrase: "haplotype analyses in several independent casecontrol populations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1514228:Population Analysis [Research Activity]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]
Processing 00000000.tx.30: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We were interested in whether meta-analysis of published association findings could provide significant evidence for the involvement of a candidate gene in AD that could then be confirmed by additional genotyping in multiple independent casecontrol materials. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "were"

Phrase: "interested in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0543488:Interested [Mental Process]

Phrase: "whether"

Phrase: "meta-analysis of published association findings"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "significant evidence for the involvement of a candidate gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in AD"

Phrase: "that"

Phrase: "could"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "confirmed by additional genotyping"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1524062:Additional [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "in multiple independent casecontrol materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]
Processing 00000000.tx.31: In reviewing the literature, the most widely studied genes in AD with three or more confirming findings, apart from APOE, were found to be A2M, ACE, BCHE, HLA-A2, LRP, PSEN1, SERPINA3 and VLDLR. 

Phrase: "In reviewing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewing [Intellectual Product]
  1000   C1704362:Reviewing [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "the literature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "the most widely studied genes in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Genes [Gene or Genome]

Phrase: "with three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "or"

Phrase: "more confirming findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "apart from APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "A2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "BCHE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "HLA-A2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019733:HLA-A2 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "LRP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: "PSEN1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "SERPINA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412050:SERPINA3 [Gene or Genome]

Phrase: "and"

Phrase: "VLDLR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421455:VLDLR [Gene or Genome]
Processing 00000000.tx.32: For a subset of these (BCHE, ACE and LRP), meta-analyses have been previously performed, in each case concluding that the studied genes do play a significant role in AD (1416). 

Phrase: "For a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of these"

Phrase: "(BCHE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "LRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0920317:meta-analyses [Research Activity]
   966 E C0282458:Meta-Analysis [Intellectual Product]
   861   C1042496:Meta [Eukaryote]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "concluding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the studied genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "do"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a significant role in AD (1416"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.33: We conducted a meta-analysis on published data (identified by exhaustive review of MEDLINE up to June, 2002) for a common Alu indel polymorphism in ACE which included 21 populations examined in 18 studies [extending upon the 12 studied populations in Narain et al. (15); Table 1]. 

Phrase: "We"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a meta-analysis on published data"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   783   C0010992:Data Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "identified by exhaustive review of MEDLINE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025141:MEDLINE [Intellectual Product]
   753   C0205396:Identified [Qualitative Concept]
   753   C0282443:Review [Intellectual Product]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1552617:Review [Idea or Concept]

Phrase: "up to June,"

Phrase: "2002"

Phrase: ")"

Phrase: "for a common Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "21 populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "examined in 18 studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0332128:Examined [Finding]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "[extending upon the 12 studied populations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439792:Extending [Spatial Concept]
   719 E C0231448:Extend [Functional Concept]

Phrase: "in Narain et al."

Phrase: "(15"

Phrase: ")"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.34: We chose to focus on ACE for several reasons. 

Phrase: "We"

Phrase: "chose to focus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205234:Focus [Spatial Concept]
   790   C1285542:focus [Functional Concept]
   756   C1707391:Choose [Activity]

Phrase: "on ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "for several reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.35: First, genetic variation in ACE has a highly reproduced effect on variation in circulating ACE protein levels (17), supporting a potential role for the gene in phenotypes which may be influenced by ACE activity. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "genetic variation in ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "has"

Phrase: "a highly reproduced effect on variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in circulating ACE protein levels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   861   C0441925:i levels [Intellectual Product]
   845   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   829   C0014440:enzyme levels [Laboratory Procedure]
   829   C1287349:enzyme levels [Laboratory or Test Result]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   710   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   710   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a potential role for the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "influenced by ACE activity."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C1150225:angiotensin I-converting enzyme activity [Molecular Function]
   853   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   853   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   840   C2258685:angiotensin converting enzyme activity [Molecular Function]
   778   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0243102:enzyme activity [Molecular Function]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021966:I- [Inorganic Chemical]
   748   C0205177:Activity [Functional Concept]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.36: Second, variation in ACE is well documented, thus facilitating haplotype-based analyses (18,19). 

Phrase: "Second, variation in ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "well documented, thus"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0205170:Well [Qualitative Concept]
   827   C1301725:Documented [Health Care Activity]
   827   C1609436:documented [Idea or Concept]
   827   C3146287:Well [Manufactured Object]
   793 E C1301746:document [Intellectual Product]
   793 E C1547673:Document [Intellectual Product]

Phrase: "facilitating"

Phrase: "haplotype-based analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.37: Third, a recent publication demonstrated the involvement of ACE in the degradation of amyloid -peptide (A), providing a putative biological link to AD (20). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "a recent publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034036:Publication [Intellectual Product,Manufactured Object]
   861   C0034037:Publication [Occupational Activity]
   861   C1704324:Publication [Intellectual Product]

Phrase: "demonstrated"

Phrase: "the involvement of ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a putative biological link to AD (20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.38: The results of the current meta-analysis corroborated earlier findings (15), indicating that the Alu insertion allele in ACE confers a modest overall increased risk for AD (OR 1.30; 95% CI 1.191.41; Table 1). 

Phrase: "The results of the current meta-analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "corroborated"

Phrase: "earlier findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the Alu insertion allele in ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "confers"

Phrase: "a modest overall increased risk for AD ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "OR"

Phrase: "1.30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.191.41"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.39: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.40: Published data for the Alu indel polymorphism in AD  To better characterize the nature of the observed association between ACE and AD, we conducted a haplotype analysis in several AD and control samples. 

Phrase: "Published data for the Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "in AD  To better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0332272:Better [Qualitative Concept]
   793 E C0205170:Well [Qualitative Concept]
   793 E C3146287:Well [Manufactured Object]

Phrase: "characterize"

Phrase: "the nature of the observed association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "between ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "AD,"

Phrase: "we"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a haplotype analysis in several AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "control samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.41: We began by genotyping seven SNPs (Table 2) in ACE in sample sets A and B (Table 3). 

Phrase: "We"

Phrase: "began by genotyping seven SNPs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0205453:Seven [Quantitative Concept]
   748   C1285573:Genotyping [Laboratory Procedure]
   714   C0439659:Begin [Temporal Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "in sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "B (Table 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0378071:b-3 [Organic Chemical,Pharmacologic Substance]
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]
   827   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Assays were created for five additional non-synonymous SNPs previously identified in African populations (18), but these were all found to be monomorphic after testing 95 Swedish control individuals. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "created for five additional non-synonymous SNPs previously"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   782   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032529:polymorphisms [Genetic Function]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   739   C0205451:Five [Quantitative Concept]
   739   C1518422:Non [Functional Concept]
   739   C1524062:Additional [Functional Concept]
   739   C1706214:Created [Activity]
   706 E C1882417:Polymorphism [Qualitative Concept]
   706 E C3244320:create [Functional Concept]

Phrase: "identified in African populations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0027567:African [Population Group]
   770   C0032659:Population [Quantitative Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1257890:Population [Population Group]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "these"

Phrase: "were"

Phrase: "all"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "monomorphic after"

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "95 Swedish control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.43: With the seven confirmed SNPs, 10 haplotypes with frequencies above 1% were identified using HAPLOTYPER (21) (Table 4). 

Phrase: "With the seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "10 haplotypes with frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018591:Haplotypes [Organism Attribute]

Phrase: "above 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HAPLOTYPER"

Phrase: "(21"

Phrase: ")"

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: In order to incorporate haplotypes into statistical analyses and for genotyping in additional populations, three SNPs were identified which could delineate or tag (22) haplotypes with frequencies above 5% (Table 4). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "incorporate"

Phrase: "haplotypes into statistical analyses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018591:Haplotypes [Organism Attribute]

Phrase: "and for genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1285573:Genotyping [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "in additional populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "three SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "which"

Phrase: "could"

Phrase: "delineate"

Phrase: "or"

Phrase: "tag (22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: ")"

Phrase: "haplotypes with frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018591:Haplotypes [Organism Attribute]

Phrase: "above 5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: LD, estimated using the r2 metric (23), was high between all of the studied SNPs (Table 5). 

Phrase: "LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the r2"

Phrase: "metric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699680:Metric [Organic Chemical,Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "high between all of the studied SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.46: Initial analyses on haplotypes generated from the three tag-SNPs did not reveal significant differences in distributions between cases and controls in sets A and B when studied independently, but significant enrichment of haplotype H1 in AD was observed by combining odds ratios (Peto's method) (24) from the 2 sets [OR 1.27; 95% CI 1.051.49 (Table 6, panels 1 and 2)]. 

Phrase: "Initial analyses on haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "generated from the three tag-SNPs"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   800   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:polymorphisms [Genetic Function]
   744   C0037179:Single [Population Group]
   744   C0037293:Tag [Neoplastic Process]
   744   C0087136:single [Finding]
   744   C0181496:Tag [Manufactured Object]
   744   C0205171:Single [Quantitative Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C1710492:TAG [Gene or Genome]
   744   C3146294:Generated [Activity]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "significant differences in distributions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0243148:control [Qualitative Concept]
   833   C1550141:Control [Substance]
   833   C1882979:Control [Conceptual Entity]
   833   C2587213:Control [Functional Concept]
   833   C3274648:Control [Qualitative Concept]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "when"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "independently,"

Phrase: "but"

Phrase: "significant enrichment of haplotype H1"

Phrase: "in AD"

Phrase: "was"

Phrase: "observed by combining odds ratios"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726   C0336789:Combine [Manufactured Object]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "(Peto's method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452238:Peto method [Therapeutic or Preventive Procedure]
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "(24"

Phrase: ")"

Phrase: "from the 2 sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "["

Phrase: "OR"

Phrase: "1.27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.051.49"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1417645:CI-49 [Gene or Genome]

Phrase: "(Table 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "panels 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.47: Based upon positive haplotype findings in sets A and B, the three tag-SNPs were then genotyped in sets C and D (Table 6, panels 3 and 4). 

Phrase: "Based upon positive haplotype findings"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   781   C1514241:Positive Finding [Finding]
           Positive
   760   C0018591:Haplotype [Organism Attribute]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2607943:findings [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0243095:Finding [Finding]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C2825141:Finding [Finding]

Phrase: "in"

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the three tag-SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "genotyped in sets C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   737   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "(Table 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "panels 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.48: Significant enrichment of H1 in sets C and D was again observed (combined OR 1.27; 95% CI 1.071.47). 

Phrase: "Significant enrichment of H1"

Phrase: "in sets C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "again"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "OR"

Phrase: "1.27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.071.47"

Phrase: ")."
Processing 00000000.tx.49: Combining results from all four groups further supported a significant excess of H1 in AD (OR 1.27; 95% CI 1.121.42) and a deficit of H2 in AD (OR 0.82; 95% CI 0.660.97). 

Phrase: "Combining results from all four"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "a significant excess of H1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1979886:Excess [Qualitative Concept]

Phrase: "in AD ("

Phrase: "OR"

Phrase: "1.27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.121.42"

Phrase: ")"

Phrase: "and"

Phrase: "a deficit of H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0162429:Deficit, NOS [Disease or Syndrome]
   770   C2987487:Deficit [Qualitative Concept]

Phrase: "in AD ("

Phrase: "OR"

Phrase: "0.82"

Phrase: "; 95% CI 0.660.97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439073:97 [Intellectual Product]
   804   C0439082:>97 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.50: Given that H1 contains the Alu insertion allele, these findings are in complete agreement with meta-analysis data, both suggesting that an equivalent common allele contributes to AD susceptibility. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that H1"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the Alu insertion allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are in complete agreement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205197:Complete [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C0725685:COMPLEAT [Food]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with meta-analysis data,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]

Phrase: "both"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an equivalent common allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "contributes to AD susceptibility."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.51: Two final models examining summed haplotype counts from all sample sets were also generated (Table 6, panels 56). 

Phrase: "Two final models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "summed haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "counts from all sample sets"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0036849:Set [Mental Process]
   760   C0370003:Sample [Substance]
   760   C0439157:counts [Quantitative Concept]
   760   C0750480:Count [Activity]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C1705566:Count [Quantitative Concept]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "(Table 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "panels 56"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.52: In these we noted, in addition to significant distortions of H1 and H2 between cases and controls, a significant deficit of H5 in AD, which suggests that there may be more than one pathogenic allele in the gene. 

Phrase: "In these"

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "in addition to significant distortions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332482:distortions [Anatomical Abnormality]
   827 E C2919017:Distortion [Qualitative Concept]

Phrase: "of H1"

Phrase: "and"

Phrase: "H2 between cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0919509:H2 [Gene or Genome]
   790   C1419394:H2 [Gene or Genome]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "a significant deficit of H5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0162429:Deficit, NOS [Disease or Syndrome]
   760   C2987487:Deficit [Qualitative Concept]

Phrase: "in AD,"

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "more than one pathogenic allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002085:Allele [Gene or Genome]
   760   C0205172:More [Functional Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0450254:Pathogenic [Organism]

Phrase: "in the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.53: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.54: Details of SNPs, PCR and DASH conditions  View this table: [in this window] [in a new window]  Table 3. 

Phrase: "Details of SNPs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1522508:Details [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "DASH conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   771   C0012634:condition [Disease or Syndrome]
   771   C0348080:Condition [Qualitative Concept]
   771   C1705253:Condition [Conceptual Entity]
   721 E C0009647:Conditioned [Mental Process]
   721 E C1701901:Conditional [Qualitative Concept]
   721 E C1963686:Conditional [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.55: Clinical materials  View this table: [in this window] [in a new window]  Table 4. 

Phrase: "Clinical materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.56: Discerned haplotypes in ACE  View this table: [in this window] [in a new window]  Table 5. 

Phrase: "Discerned haplotypes in ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018591:Haplotypes [Organism Attribute]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.57: Pairwise LD for ACE markers  View this table: [in this window] [in a new window]  Table 6. 

Phrase: "Pairwise LD for ACE markers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.58: Haplotype associations  Based upon its putative involvement in -amyloid degradation (20), we explored the possible influence of ACE variants on CSF levels of A42. 

Phrase: "Haplotype associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "Based upon its putative involvement in -amyloid degradation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0243125:degradation [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699900:Degradation [Organism Function]
   744   C1314939:Involvement [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "explored"

Phrase: "the possible influence of ACE variants"

Phrase: "on CSF levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441889:Levels [Qualitative Concept]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of A42."
Processing 00000000.tx.59: CSF A42 levels were measured as previously described (25) in a total of 237 cases and 49 controls from sets A and C. 

Phrase: "CSF A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured as previously"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "in a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 237 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "49 controls from"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.60: Significantly lower levels of A42 were observed in the AD group compared with controls, consistent with what has been shown in numerous previous studies (Student's t-test, P<0.0001) (26). 

Phrase: "Significantly lower levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed in the AD group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1441672:Observed [Functional Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "consistent with what"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown in numerous previous studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C0439064:Numerous [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   726 E C0557651:Study [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "(Student's t-test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.61: To perform an analysis of ACE haplotypes and A42 levels, a clade strategy was employed similar to that used by Soubrier et al. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "an analysis of ACE haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "A42 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "a clade strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "used by Soubrier et al."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1273517:Used by [Finding]
           used
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.62: (27). 

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.63: Previous studies on haplotype diversity in ACE have suggested a cladistic structure involving three major clades (A, B and C), where clade A has been shown to be associated with low plasma ACE activity, and clades B and C with higher activity (18,19,27). 

Phrase: "Previous studies on haplotype diversity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a cladistic structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "three major clades"

Phrase: "(A,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C), where clade"

Phrase: "A"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with low plasma ACE activity,"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   849   C1150225:angiotensin I-converting enzyme activity [Molecular Function]
   818   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   818   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   810   C2258685:angiotensin converting enzyme activity [Molecular Function]
   764   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C0243102:enzyme activity [Molecular Function]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021966:I- [Inorganic Chemical]
   742   C0032105:Plasma [Body Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1299352:Low [Qualitative Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1550472:low [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "clades B"

Phrase: "and"

Phrase: "C with higher activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "(18,"

Phrase: "19,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.64: We noted from the work of Soubrier et al. 

Phrase: "We"

Phrase: "noted from the work of Soubrier et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0043227:Work [Occupational Activity]
   711   C1316572:Note [Clinical Attribute]
   711   C1317574:Note [Intellectual Product]
   711   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.65: (27) and Farrall et al. 

Phrase: "(27"

Phrase: ")"

Phrase: "and"

Phrase: "Farrall et al."
Processing 00000000.tx.66: (19) that haplotypes defined by as few as two SNPs (one on either side of a putative ancestral recombination or gene conversion event) could be efficiently assigned to one of the three major clades. 

Phrase: "(19"

Phrase: ")"

Phrase: "that haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "defined by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1704788:Defined [Conceptual Entity]
   833   C3539106:Defined [Intellectual Product]

Phrase: "as"

Phrase: "few as two SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205388:Few [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(one on either side of a putative ancestral recombination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0205092:one side [Spatial Concept]
   742   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "gene conversion event"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Event [Event]
   734   C0017259:Gene Conversion [Genetic Function]

Phrase: ")"

Phrase: "could"

Phrase: "be"

Phrase: "efficiently"

Phrase: "assigned to one of the three major clades."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205164:Major [Qualitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C1516050:Assigned [Functional Concept]
   744   C1552601:assigned [Intellectual Product]
Processing 00000000.tx.67: Using two of the three tag SNPs to predict haplotypes (ACE3 and ACE6; Table 4), and modeling effects by ANOVA, significant differences in CSF-A42 levels between ACE clades were observed (Fig.1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two of the three tag SNPs to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205448:Two [Quantitative Concept]

Phrase: "predict"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "(ACE3"

Phrase: "and"

Phrase: "ACE6"

Phrase: "; Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "modeling effects by ANOVA,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "significant differences in CSF-A42 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between ACE clades"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: These differences, while subtle, were consistent with the presence of a detrimental allele(s) in clade A (which contains H1) and/or a protective role for an allele(s) within clade B (containing H2). 

Phrase: "These differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "while"

Phrase: "subtle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1710238:Subtlety [Clinical Attribute]

Phrase: "were"

Phrase: "consistent with the presence of a detrimental allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "("

Phrase: "s) in clade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "A ("

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "H1"

Phrase: ")"

Phrase: "and/or"

Phrase: "a protective role for an allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "s) within clade B (containing H2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332256:Containing [Functional Concept]
   753   C0919509:H2 [Gene or Genome]
   753   C1419394:H2 [Gene or Genome]
   753   C2603362:S' [Clinical Attribute]
   753   C2700400:Containing [Activity]

Phrase: ")."
Processing 00000000.tx.69: However, we also noted significant differences in individuals bearing the combination of haplotypes belonging to clades B and C compared with other groups (Fig.1). 

Phrase: "However,"

Phrase: "we also"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "significant differences in individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0021228:Individual Differences [Mental Process]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the combination of haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "belonging to clades B"

Phrase: "and"

Phrase: "C"

Phrase: "compared with other groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1707455:Compared [Activity]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.70: View larger version (25K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.71: Mean values (SEM) of A42 levels for AD patients with different phased multilocus genotypes as estimated using the HAPLOTYPER program and binned by clade affiliation. 

Phrase: "Mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(SEM) of A42 levels"

Phrase: "for AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with different phased multilocus genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "as"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HAPLOTYPER program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "binned by clade affiliation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1510825:Affiliation [Qualitative Concept]
   737   C1879840:Bin [Quantitative Concept]
Processing 00000000.tx.72: The number of individuals in each group is shown in parentheses. 

Phrase: "The number of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "shown in parentheses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.73: Significance was determined both with ANOVA (shown at top left) and by the KruskalWallis non-parametric test (P=0.02). 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "both with ANOVA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0238767:Both [Spatial Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1706086:Both [Qualitative Concept]
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]

Phrase: "("

Phrase: "shown at top left"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
   770   C1704458:Top [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and by the KruskalWallis non-parametric test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1709255:Non-Parametric Test [Intellectual Product]
   778   C1711157:Parametric Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C1515981:And [Idea or Concept]
   748   C1518422:Non [Functional Concept]

Phrase: "(P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.74: There was no evidence of confounding effects of age, duration, or gender. 

Phrase: "There"

Phrase: "was"

Phrase: "no evidence of confounding effects of age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "duration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "or"

Phrase: "gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.75: Approximately 7% of variation in CSF A42 levels is explained in this model.  

Phrase: "Approximately 7% of variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205419:Variation [Qualitative Concept]
   770   C0332232:Approximately [Qualitative Concept]

Phrase: "in CSF A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "explained in this model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]
Processing 00000000.tx.76: With substantial evidence of ACE haplotypes influencing AD, we investigated whether any of the single markers that had been typed in all 4 case-control populations would also exhibit significant association. 

Phrase: "With substantial evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "of ACE haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0018591:Haplotypes [Organism Attribute]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "influencing"

Phrase: "AD,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "any of the single markers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "typed in all 4 case-control populations"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0872128:case control [Health Care Activity]
   774   C0032662:Population Control [Occupation or Discipline]
   757   C0441732:Type 4 [Classification]
   757   C1707504:Control Type [Research Activity]
   757   C1879930:Control Type [Intellectual Product]
   748   C0032659:Population [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0868928:Case [Functional Concept]
   748   C1257890:Population [Population Group]
   748   C1550141:Control [Substance]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0332307:Type [Qualitative Concept]
   714   C1547052:*Type [Quantitative Concept]

Phrase: "would"

Phrase: "also"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "significant association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.77: Tests of genotype distributions between cases and controls revealed all of the three tag-SNPs to be significantly associated with AD (Table 7). 

Phrase: "Tests of genotype distributions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "all of the three tag-SNPs to"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0032529:polymorphisms [Genetic Function]
   742   C0037179:Single [Population Group]
   742   C0037293:Tag [Neoplastic Process]
   742   C0087136:single [Finding]
   742   C0181496:Tag [Manufactured Object]
   742   C0205171:Single [Quantitative Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0444868:All [Quantitative Concept]
   742   C1710492:TAG [Gene or Genome]
   742   C3539085:All [Idea or Concept]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "be"

Phrase: "significantly"

Phrase: "associated with AD (Table 7"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.78: The strongest effect was found for the ACE6 marker, which is located in the ACE promoter (OR 1.64; 95% CI 1.331.94). 

Phrase: "The strongest effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "found for the ACE6 marker,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0005516:Marker [Clinical Attribute]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "located in the ACE promoter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: "OR"

Phrase: "1.64"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.331.94"

Phrase: ")."
Processing 00000000.tx.79: In agreement with haplotype findings, the allele of this site that was enriched in AD is present on the H1 haplotype (Table 6). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with haplotype findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "the allele of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "that"

Phrase: "was"

Phrase: "enriched in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0359583:enriched [Food]

Phrase: "is"

Phrase: "present on the H1 haplotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(Table 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: To quantify the impact of this SNP on AD, we calculated population attributable risk (28), which suggested under a dominant model that the detrimental allele at this site (or an allele in strong LD with it) may contribute to as much as 35% of AD in the general population. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the impact of this SNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "on AD,"

Phrase: "we"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "population attributable risk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1514229:Population Attributable Risk [Quantitative Concept]
   913   C0242444:population risk [Population Group]
   913   C2987720:Population risk [Quantitative Concept]
   901   C0814766:Attributable Risk [Qualitative Concept]
   827   C0032659:Population [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C0596130:Attributable [Mental Process]
   827   C1257890:Population [Population Group]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "suggested under a dominant model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1527180:Dominant [Functional Concept]
   760   C3161035:Model [Intellectual Product]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the detrimental allele at this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "("

Phrase: "or"

Phrase: "an allele in strong LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "with it)"

Phrase: "may"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "much as 35% of AD"

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.81: View this table: [in this window] [in a new window]  Table 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.82: Single marker associations  Since essentially all existing data on variation in ACE in relation to AD are based upon the Alu indel polymorphism, it was considered necessary to obtain genotypes for this marker in at least one of the studied sample sets. 

Phrase: "Single marker associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "Since"

Phrase: "essentially"

Phrase: "all existing data on variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "in relation to AD"

Phrase: "are"

Phrase: "based upon the Alu indel polymorphism,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1956002:Indel [Genetic Function]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "it"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "necessary to"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "genotypes for this marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "in"

Phrase: "at least one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "of the studied sample sets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.83: This was done for set D materials, in addition to the three tag-SNPs. 

Phrase: "This"

Phrase: "was"

Phrase: "done for set D materials,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0036849:Set [Mental Process]
   760   C0520510:Materials [Substance]
   760   C1272695:Done [Qualitative Concept]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1442518:Set [Functional Concept]
   760   C1511760:Deletion [Genetic Function]
   760   C1705195:Set [Conceptual Entity]
   760   C1880274:Deletion [Activity]
   760   C2746065:Done [Temporal Concept]

Phrase: "in addition to the three tag-SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.84: Standard chi-square tests did not reveal any significant differences for alleles or genotypes between cases and controls for the Alu indel marker (P=0.6 and 0.9, respectively; data not shown). 

Phrase: "Standard chi-square tests"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0008041:Tests, Chi-Square [Intellectual Product]
   861   C1552646:chi square [Quantitative Concept]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0205120:Square [Spatial Concept]
   812   C0392366:Tests [Intellectual Product]
   812   C1552595:Square [Intellectual Product]
   812   C1720589:Chi [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any significant differences for alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "genotypes between cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "controls for the Alu indel marker"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005516:Marker [Clinical Attribute]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C1956002:Indel [Genetic Function]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(P=0.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "0.9,"

Phrase: "respectively"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Estimates of LD between the Alu indel polymorphism and other studied markers in set D ranged from r2=0.46 to r2=0.91 (Table 5).  

Phrase: "Estimates of LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750572:estimates [Quantitative Concept]

Phrase: "between the Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "other studied markers in set D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1955343:Other markers [Clinical Attribute]
   719   C0005516:Marker [Clinical Attribute]

Phrase: "ranged from r2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "=0.46 to r2"

Phrase: "=0.91"

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We have employed multiple independent clinical materials to provide reproducible evidence that variants of ACE have a considerable impact upon AD. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "multiple independent clinical materials to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "reproducible evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that variants of ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "have"

Phrase: "a considerable impact upon AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.87: Results are consistent with a modest, but highly significant detrimental effect of a common allele of ACE that because of its high frequency may underlie a large proportion of AD cases in the general population. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with a modest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "but"

Phrase: "highly significant detrimental effect of a common allele of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1280500:Effect [Qualitative Concept]
   735   C2348382:Effect [Qualitative Concept]

Phrase: "that because of its high frequency"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0205212:High frequency [Temporal Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "may"

Phrase: "underlie"

Phrase: "a large proportion of AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.88: The validity of findings is further independently substantiated by a meta-analysis of published studies on variation in ACE and AD. 

Phrase: "The validity of findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2349101:Validity [Quantitative Concept]

Phrase: "is"

Phrase: "further independently"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "substantiated by a meta-analysis of published studies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0034037:Published [Occupational Activity]
   744   C0936012:Analysis [Research Activity]
   744   C0947630:studies [Laboratory Procedure]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]
   744   C1704324:Published [Intellectual Product]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "on variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.89: While the majority of prior studies have been of limited scope, employing small populations and focussing exclusively upon a single Alu indel polymorphism in ACE, their utility in meta-analysis is clearly underscored here, highlighting the critical importance of the data from negative association studies being published and/or made readily available to the general public. 

Phrase: "While"

Phrase: "the majority of prior studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "have"

Phrase: "been of limited scope,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439801:Limited [Functional Concept]
   770   C1710028:Scope [Conceptual Entity]
   770   C3542948:Limited [Intellectual Product]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "small populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "focussing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205234:Focus [Spatial Concept]
   966   C1285542:focus [Functional Concept]

Phrase: "exclusively upon a single Alu indel polymorphism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0032529:Polymorphism [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C1882417:Polymorphism [Qualitative Concept]
   748   C1956002:Indel [Genetic Function]

Phrase: "in ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "their utility in meta-analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]

Phrase: "is"

Phrase: "clearly"

Phrase: "underscored"

Phrase: "here,"

Phrase: "highlighting"

Phrase: "the critical importance of the data"

Phrase: "from negative association studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "being"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "and/or"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "readily available to the general public."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0470187:Available [Functional Concept]
Processing 00000000.tx.90: The shortcomings of previous studies on the Alu indel illustrates the importance of typing multiple SNPs (or other types of variation), of using haplotype based approaches, and of having some understanding of LD structure in regions of interest when undertaking association studies. 

Phrase: "The shortcomings of previous studies"

Phrase: "on the Alu indel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1956002:Indel [Genetic Function]

Phrase: "illustrates"

Phrase: "the importance of typing multiple SNPs"

Phrase: "("

Phrase: "or"

Phrase: "other types of variation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "haplotype based approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "and of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "having"

Phrase: "some"

Phrase: "understanding of LD structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0162340:Understanding [Mental Process]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0678594:Structure [Spatial Concept]

Phrase: "in regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "when"

Phrase: "undertaking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041666:Undertaking [Occupation or Discipline]

Phrase: "association studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.91: In this context, it is noteworthy that a recent study has indicated that the Alu indel polymorphism can be excluded as the site which influences ACE levels (29). 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "excluded as the site"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C1554077:Excluded [Idea or Concept]
   770   C2825164:Site [Spatial Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "which"

Phrase: "influences"

Phrase: "ACE levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0441925:i levels [Intellectual Product]
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771 E C0456079:Level [Classification]
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.92: Within our own data set, the ACE6 marker, which showed the strongest effect on AD, was in the weakest LD with the Alu indel (r2=0.46). 

Phrase: "Within our own data set,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "the ACE6 marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the strongest effect on AD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1883473:Ad Effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was in the weakest LD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C1421478:WAS [Gene or Genome]
   719   C0004093:Weak [Sign or Symptom]
   719   C1762617:Weak [Qualitative Concept]

Phrase: "with the Alu indel (r2"

Phrase: "=0.46"

Phrase: ")."
Processing 00000000.tx.93: In contrast, the ACE3 marker, which showed the weakest effect on AD, was in the strongest LD with the Alu indel (r2=0.91). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the ACE3 marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the weakest effect on AD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1883473:Ad Effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was in the strongest LD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C1421478:WAS [Gene or Genome]
   719   C0442821:Strong [Qualitative Concept]

Phrase: "with the Alu indel (r2"

Phrase: "=0.91"

Phrase: ")."
Processing 00000000.tx.94: Based upon these premises, we consider it plausible that reliance upon the Alu indel may have contributed to many of the negative findings previously reported. 

Phrase: "Based upon these premises,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "it plausible"

Phrase: "that reliance upon the Alu indel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0290627:reliance [Biomedical or Dental Material]

Phrase: "may"

Phrase: "have"

Phrase: "contributed to many of the negative findings previously"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   754   C1513916:Negative Finding [Finding]
           Negative
   744   C0205160:Negative [Qualitative Concept]
   744   C2607943:findings [Functional Concept]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711   C1880177:Contribute [Activity]
   711 E C2825141:Finding [Finding]

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.95: Assuming that ACE6 is in tight LD with a true pathogenic variant(s), based upon the odds ratio we report (1.64), sample sizes on the order of 300 cases and 300 controls are required to achieve 80% power at a 0.05 significance level (surpassing sample sizes for most previous studies; Table 1). 

Phrase: "Assuming"

Phrase: "that ACE6"

Phrase: "is in tight LD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0439816:Tight [Qualitative Concept]
   760   C0453911:tight [Manufactured Object]

Phrase: "with a true pathogenic variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "based upon the odds ratio"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0028873:Odds Ratio [Quantitative Concept]
   781   C0004792:Base Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "(1.64"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "sample sizes on the order of 300 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242618:Sizes, Sample [Quantitative Concept]
   744   C0456389:SIZES [Spatial Concept]

Phrase: "and"

Phrase: "300 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "80% power at a 0.05 significance level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "("

Phrase: "surpassing"

Phrase: "sample sizes for most previous studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242618:Sizes, Sample [Quantitative Concept]
   753   C0456389:SIZES [Spatial Concept]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: Diminishing LD requires a proportional increase in sample size to maintain power, the relationship being 1/r2 (30). 

Phrase: "Diminishing LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "requires"

Phrase: "a proportional increase in sample size to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1268652:Increase in size [Finding]
           increase size
   748   C0442805:Increase [Functional Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "the relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "being"

Phrase: "1/r2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700066:1/R2 [Quantitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.97: Thus, use of the Alu indel would dictate that sample size needs to be more than doubled to have reasonable (80%) power to detect the effect. 

Phrase: "Thus,"

Phrase: "use of the Alu indel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "would"

Phrase: "dictate"

Phrase: "that sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205172:More [Functional Concept]

Phrase: "doubled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:doubled [Functional Concept]
   966 E C1705764:Double [Activity]
   966 E C1705765:Double [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "reasonable"

Phrase: "(80%"

Phrase: ")"

Phrase: "power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.98: A series of experiments have been previously undertaken aimed at refining the location of variants in ACE which influence circulating ACE levels (29). 

Phrase: "A series of experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "undertaken"

Phrase: "aimed at refining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]

Phrase: "the location of variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]

Phrase: "in ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "which"

Phrase: "influence"

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "ACE levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0441925:i levels [Intellectual Product]
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771 E C0456079:Level [Classification]
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.99: Findings have suggested the presence of one or more variants that contribute to the ACE trait, but as yet none have been tested in isolation for their functional role. 

Phrase: "Findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "more variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "contribute to the ACE trait,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0599883:Trait [Organism Attribute]
   744   C1880177:Contribute [Activity]

Phrase: "but as yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "none"

Phrase: "have"

Phrase: "been"

Phrase: "tested in isolation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "for their functional role."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1705810:Functional Role [Conceptual Entity]
           Role
   861   C0035820:Role [Social Behavior]
Processing 00000000.tx.100: Specifically, both intragenic and promoter variants were observed to act independently to influence ACE levels (29). 

Phrase: "Specifically,"

Phrase: "both intragenic"

Phrase: "and"

Phrase: "promoter variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "independently to"

Phrase: "influence"

Phrase: "ACE levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0441925:i levels [Intellectual Product]
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771 E C0456079:Level [Classification]
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.101: While all of our studied SNPs are shown to be associated with AD, the strength of the finding for the common ACE6 promoter variant alludes to perturbed expression of ACE as potentially underlying its effects upon AD. 

Phrase: "While"

Phrase: "all of our studied SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0444868:All [Quantitative Concept]
   748   C3539085:All [Idea or Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with AD,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the strength of the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]

Phrase: "for the common ACE6 promoter variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "alludes"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perturbed"

Phrase: "expression of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   716   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "as"

Phrase: "potentially"

Phrase: "underlying"

Phrase: "its effects upon AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1883473:Ad Effect [Qualitative Concept]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.102: However, there is no way to exclude one or more alternative sites, as the high level of LD between all studied SNPs is prohibitive in terms of providing further resolution, at least in European populations. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "no way to"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more alternative sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "as"

Phrase: "the high level of LD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299351:High [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2700149:HIGH [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "between all studied SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "prohibitive in terms of providing further resolution,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in European populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.103: A number of sequencing efforts have exhaustively screened the transcribed region of ACE and while sequence variants outside the studied region may be relevant, none of the yet identified polymorphisms are represented by obvious pathogenic alleles. 

Phrase: "A number of sequencing efforts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2348184:Sequence Number [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "exhaustively"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "the transcribed region of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "while"

Phrase: "sequence variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the studied region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "none of the yet identified polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0032529:polymorphisms [Genetic Function]
   753   C0205396:Identified [Qualitative Concept]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "represented by obvious pathogenic alleles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Alleles [Gene or Genome]
   760   C0450254:Pathogenic [Organism]
   726   C1882932:Represent [Activity]
Processing 00000000.tx.104: Our observations suggest an equivalence between the alleles that are associated with AD and those that are associated with reduced circulating ACE levels (17). 

Phrase: "Our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an equivalence between the alleles"

Phrase: "that"

Phrase: "are"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "those that"

Phrase: "are"

Phrase: "associated with reduced circulating ACE levels"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   818   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   818   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   764   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C0014440:enzyme levels [Laboratory Procedure]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1287349:enzyme levels [Laboratory or Test Result]
   762   C0441925:i levels [Intellectual Product]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021966:I- [Inorganic Chemical]
   742   C0175630:Circulating [Functional Concept]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1547707:Level [Geographic Area]
   708 E C1706221:Associate [Professional or Occupational Group]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.105: The implied relationship is thus that reduced activity of ACE, either by modification of the protein or reduced expression levels, underlies an increase in susceptibility to AD. 

Phrase: "The implied relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "is"

Phrase: "thus"

Phrase: "that reduced activity of ACE,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   855   C1150225:angiotensin I-converting enzyme activity [Molecular Function]
   815   C2258685:angiotensin converting enzyme activity [Molecular Function]
   770   C0086439:Reduced Activity [Sign or Symptom]
   767   C0243102:enzyme activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "either by modification of the protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033666:Protein Modification [Molecular Function]
   783   C2263112:protein modification [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "or"

Phrase: "reduced expression levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "underlies"

Phrase: "an increase in susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "to AD."
Processing 00000000.tx.106: Further, recent work has indicated that ACE contributes to the metabolism of A, whereby increased A degradation may prevent its aggregation, thus reducing susceptibility to AD (20). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "contributes to the metabolism of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C1880177:Contribute [Activity]

Phrase: "whereby"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "its aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "thus"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "susceptibility to AD (20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: In principle, this would be consistent with our findings in terms of association with AD. 

Phrase: "In principle,"

Phrase: "this"

Phrase: "would"

Phrase: "be"

Phrase: "consistent with our findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in terms of association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with AD."
Processing 00000000.tx.108: However, in addition to effects upon AD, we also investigated the potential influence of ACE variants on CSF-A42. 

Phrase: "However,"

Phrase: "in addition to effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "upon AD,"

Phrase: "we also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the potential influence of ACE variants"

Phrase: "on CSF-A42."
Processing 00000000.tx.109: While findings were significant, they were not amendable to simple interpretation. 

Phrase: "While"

Phrase: "findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "significant,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "not amendable to simple interpretation."
Processing 00000000.tx.110: The primary haplotype groups (belonging to A and B clades) differed in terms of levels of CSF-A42, with lower levels in clade A compared to clade B, but the lowest CSF-A42 levels were observed in the group in which clade B and clade C haplotypes are found in combination. 

Phrase: "The primary haplotype groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0680395:primary group [Population Group]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "(belonging to A"

Phrase: "and"

Phrase: "B clades"

Phrase: ")"

Phrase: "differed in terms of levels of CSF-A42,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0441889:Levels [Qualitative Concept]
   744   C3540512:CSF [Therapeutic or Preventive Procedure]
   711 E C0456079:Level [Classification]
   711   C1515273:Term [Temporal Concept]
   711 E C1547707:Level [Geographic Area]
   711   C1705313:Term [Idea or Concept]
   711   C2826302:TERM [Intellectual Product]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "with lower levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in clade"

Phrase: "A compared to clade B,"

Phrase: "but"

Phrase: "the lowest CSF-A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed in the group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1441672:Observed [Functional Concept]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "in which clade B"

Phrase: "and"

Phrase: "clade C haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "found in combination."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0150312:Found [Quantitative Concept]
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.111: While this implies possible allelic interaction, we note that a confirmation of such an effect might come appropriately from a study of existing data on plasma ACE levels (e.g. from Soubrier et al., 27). 

Phrase: "While"

Phrase: "this"

Phrase: "implies"

Phrase: "possible allelic interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "we"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "a confirmation of such"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "might"

Phrase: "come"

Phrase: "appropriately from a study of existing data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0681873:study data [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C2603343:Study [Research Activity]
   748   C3245479:data [Medical Device]

Phrase: "on plasma ACE levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   858   C0441925:i levels [Intellectual Product]
   827   C0014440:enzyme levels [Laboratory Procedure]
   827   C1287349:enzyme levels [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "("

Phrase: "e.g."

Phrase: "from Soubrier et al.,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.112: An effect of this nature, if real, would most likely also contribute to inconsistencies in casecontrol studies. 

Phrase: "An effect of this nature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "if"

Phrase: "real,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237400:Real [Qualitative Concept]
  1000   C3272377:REAL [Intellectual Product]

Phrase: "would"

Phrase: "most likely also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "contribute to inconsistencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1880177:Contribute [Activity]
   706   C0442809:Inconsistent [Qualitative Concept]

Phrase: "in casecontrol studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.113: We regard our findings on CSF-A42 as preliminary, clearly in need of further study, but nonetheless worthy of mention here. 

Phrase: "We"

Phrase: "regard"

Phrase: "our findings on CSF-A42"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "as preliminary, clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439611:Preliminary [Temporal Concept]

Phrase: "in need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "of further study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "but"

Phrase: "nonetheless worthy of mention here."
Processing 00000000.tx.114: To date, the only well-replicated risk factor for AD is the 4 allele of APOE (4). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "the only well-replicated risk factor for AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035648:Risk factor [Quantitative Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "the 4 allele of APOE (4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C3642141:APOE*4 Allele [Gene or Genome]
   753   C0002085:Allele [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.115: It is worth noting, however, that variants of both APOE and ACE have been found to influence a number of phenotypes, including cardiovascular disease and various measures of lipid metabolism (31). 

Phrase: "It"

Phrase: "is worth noting,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "however,"

Phrase: "that variants of both APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "a number of phenotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "various measures of lipid metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0079809:Measures [Quantitative Concept]
   760   C1879489:Measures [Functional Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: In addition, the 4 allele of APOE has been shown to be associated with reduced CSF-A42 (32), an effect which may be shared by variants of ACE. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the 4 allele of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C3642141:APOE*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with reduced CSF-A42"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0392756:Reduced [Qualitative Concept]
   760   C3540512:CSF [Therapeutic or Preventive Procedure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "shared by variants of ACE."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0205419:variants [Qualitative Concept]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0237876:shared [Social Behavior]
   744   C1522138:Shared [Functional Concept]
Processing 00000000.tx.117: In view of all of these findings, common biological pathways linking the effects of APOE, ACE, lipid and A metabolism seem to be implied in AD aetiology. 

Phrase: "In view of all"

Phrase: "of these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "common biological pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "the effects of APOE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "A metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "implied in AD aetiology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015127:aetiology [Functional Concept]
   770   C1314792:Aetiology [Functional Concept]
   770   C1524003:Etiology [Conceptual Entity]
Processing 00000000.tx.118: In summary, results indicate that genetic variation in ACE substantially contributes to AD susceptibility. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that genetic variation in ACE substantially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0042333:Genetic Variation [Natural Phenomenon or Process]
   742   C0205419:Variation [Qualitative Concept]

Phrase: "contributes to AD susceptibility."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.119: This represents the strongest evidence to date of a second gene, in addition to APOE, that influences the sporadic form of AD. 

Phrase: "This"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the strongest evidence to date of a second gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in addition to APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "that"

Phrase: "influences"

Phrase: "the sporadic form of AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.120: However, while the data are consistent with one common susceptibility allele of ACE, we cannot exclude the possibility that multiple pathogenic alleles exist across the gene as has previously been hypothesized to be the case (29). 

Phrase: "However,"

Phrase: "while"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with one common susceptibility allele of ACE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that multiple pathogenic alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314632:Multiple alleles [Genetic Function]
   827   C0002085:Alleles [Gene or Genome]

Phrase: "exist across the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "as"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.121: The identification of functional variants of ACE thus represents one of the last hurdles to overcome before the mechanism of its involvement in AD can be defined.  

Phrase: "The identification of functional variants of ACE thus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0020792:Identification [Mental Process]
   738   C0205396:Identification [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "one of the last hurdles to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "overcome before the mechanism of its involvement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441712:Mechanism [Functional Concept]
   748   C1314939:Involvement [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
   748   C2983310:Overcome [Activity]

Phrase: "in AD"

Phrase: "can"

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.122: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Clinical materials Details of all clinical materials are provided in Table 3. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clinical materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "Details of all clinical materials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0520510:Materials [Substance]
   760   C1522508:Detail [Qualitative Concept]
   760   C1561567:detail [Functional Concept]

Phrase: "are"

Phrase: "provided in Table 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.123: Swedish LOAD sets A and C consisted of a total of 390 patients. 

Phrase: "Swedish LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1550025:Load [Idea or Concept]
   861   C1704782:Load [Manufactured Object]
   861   C1708715:Load [Activity]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "consisted of a total of 390 patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   714   C0332529:CONSIST [Qualitative Concept]
Processing 00000000.tx.124: Set A was recruited from a prospective longitudinal study at Gteborg University of patients with dementia. 

Phrase: "Set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "was"

Phrase: "recruited from a prospective longitudinal study"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0033522:prospective longitudinal study [Research Activity]
           prospective study
   790   C0023981:Longitudinal Study [Research Activity]
           prospective
   783   C1709709:Prospective Study [Research Activity]
   753   C0205127:Longitudinal [Spatial Concept]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "at Gteborg University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.125: Set C was recruited as part of a longitudinal geriatric population study in Pite, Sweden. 

Phrase: "Set C"

Phrase: "was"

Phrase: "recruited as part of a longitudinal geriatric population study"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0681876:Population Study [Research Activity]
   764   C1292711:Part of [Spatial Concept]
   762   C0023981:Longitudinal Study [Research Activity]
   762 E C2348561:Study Population [Population Group]
   742   C0032659:Population [Quantitative Concept]
   742   C0205127:Longitudinal [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C0557651:Study [Manufactured Object]
   742   C1257890:Population [Population Group]
   742   C1704440:Geriatric [Qualitative Concept]
   742   C1709471:Part [Quantitative Concept]
   742   C1999167:geriatric [Population Group]
   742   C2603343:Study [Research Activity]

Phrase: "in Pite,"

Phrase: "Sweden."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]
Processing 00000000.tx.126: In the AD group, 297 had a clinical and 93 a neuropathological diagnosis. 

Phrase: "In the AD group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "297"

Phrase: "had"

Phrase: "a clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "93"

Phrase: "a neuropathological diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.127: All clinically diagnosed AD patients underwent a thorough investigation, which included a medical history, physical, neurological and psychiatric examination, screening laboratory tests, ECG, X-ray of the chest, EEG and computerized tomography (CT) of the brain. 

Phrase: "All clinically"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "underwent"

Phrase: "a thorough investigation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a medical history,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0262926:Medical History [Finding]
           History
  1000   C1704706:Medical History [Idea or Concept]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0205476:Medical [Functional Concept]
   861   C0262512:History, NOS [Organism Attribute]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "physical,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031809:Physical [Health Care Activity]
  1000   C0205485:Physical [Functional Concept]
  1000   C1509143:Physical [Finding]

Phrase: "neurological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205494:Neurological [Qualitative Concept]
  1000   C2707261:Neurological [Clinical Attribute]

Phrase: "and"

Phrase: "psychiatric examination,"

Phrase: "screening"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
   966 E C1305399:screen [Functional Concept]
   966 E C1705053:Screen [Medical Device]

Phrase: "laboratory tests,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0022885:Laboratory Tests [Laboratory Procedure]
           Tests
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C0392366:Tests [Intellectual Product]
   861   C3244292:laboratory [Functional Concept]
   827 E C0039593:Test [Functional Concept]

Phrase: "ECG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1623258:ECG NOS [Diagnostic Procedure]

Phrase: "X-ray of the chest,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   900   C0039985:X-ray of chest NOS [Diagnostic Procedure]
           Chest X-ray
   844   C1114557:Chest X-ray [Clinical Attribute]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   802 E C0856599:Breast X-ray [Diagnostic Procedure]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C2314876:ray [Fish]

Phrase: "EEG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013819:EEG, NOS [Diagnostic Procedure]

Phrase: "and"

Phrase: "computerized tomography (CT) of the brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0412585:computerized tomography brain [Diagnostic Procedure]
   806   C0040405:Computerized tomography [Diagnostic Procedure]
           tomography
   760   C0040395:tomography [Diagnostic Procedure]
Processing 00000000.tx.128: Clinical AD diagnoses were made according to the NINCDS-ADRDA criteria (33). 

Phrase: "Clinical AD diagnoses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0332140:Diagnosis, clinical [Qualitative Concept]
   827   C0011900:Diagnoses [Finding]
   793 E C1704338:diagnosis [Qualitative Concept]
   793 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "made according to the NINCDS-ADRDA criteria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243161:criteria [Intellectual Product]
   748   C0680240:according [Social Behavior]
   714   C1881534:Make [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.129: All neuropathologically diagnosed AD patients also fulfilled the clinical NINCDS-criteria for probable AD and met the neuropathological CERAD criteria for definitive AD (34). 

Phrase: "All neuropathologically"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "AD patients also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the clinical NINCDS-criteria for probable AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the neuropathological CERAD criteria"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   844   C1540677:neuropathology disease [Pathologic Function]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0034975:Registry [Intellectual Product]
   790   C0243161:criteria [Intellectual Product]
   790   C0443211:establish [Qualitative Concept]
   790   C1513822:Consortium [Professional or Occupational Group]
   790   C1880171:Consortium [Professional or Occupational Group]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "for definitive AD (34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443196:Definitive [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.130: Swedish controls for set A consisted of 77 healthy volunteers and 108 autopsy individuals. 

Phrase: "Swedish controls for set"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "A"

Phrase: "consisted of 77 healthy volunteers"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C1708335:Healthy Volunteers [Population Group]
   760   C0042960:Volunteers [Professional or Occupational Group]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1549078:Volunteer [Idea or Concept]
   726 E C1997894:volunteer [Population Group]

Phrase: "and"

Phrase: "108 autopsy individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
Processing 00000000.tx.131: The healthy volunteers were individuals without history, symptoms or signs of psychiatric or neurological disease, malignant disease, or systemic disorders. 

Phrase: "The healthy volunteers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1708335:Healthy Volunteers [Population Group]
   861   C0042960:Volunteers [Professional or Occupational Group]
   827 E C1549078:Volunteer [Idea or Concept]
   827 E C1997894:volunteer [Population Group]

Phrase: "were"

Phrase: "individuals without history,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "or"

Phrase: "signs of psychiatric"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   841   C0233400:Psychiatric sign [Sign or Symptom]
   790   C0220912:signs [Functional Concept]
   790   C0220913:signs [Manufactured Object]
   790   C0311392:SIGNS [Finding]
   756 E C1547188:Sign [Idea or Concept]

Phrase: "or"

Phrase: "neurological disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "malignant disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0442867:Malignant disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205282:Malignant [Qualitative Concept]
   861   C0334590:MALIGNANT [Neoplastic Process]
   861   C1533592:MALIGNANT [Neoplastic Process]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "systemic disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0442893:Systemic Disorder [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.132: Cognitive status was examined using MMSE (35), and individuals with scores below 28 were not included as controls. 

Phrase: "Cognitive status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MMSE (35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451306:MMSE [Diagnostic Procedure]
   861   C3538742:MMSE [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "individuals with scores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "below 28"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included as controls."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332257:included [Functional Concept]
   790   C3538986:INCLUDED [Gene or Genome]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756 E C1552866:include [Idea or Concept]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756 E C2700399:Include [Activity]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.133: The autopsy control group consisted of patients who had died from cardiac disease or malignant disease. 

Phrase: "The autopsy control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisted of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "who"

Phrase: "had"

Phrase: "died from cardiac disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0018799:Disease, Cardiac [Disease or Syndrome]
   770   C0011065:Died [Organism Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C1522601:Cardiac [Spatial Concept]
   770   C1546956:Died [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "malignant disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0442867:Malignant disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205282:Malignant [Qualitative Concept]
   861   C0334590:MALIGNANT [Neoplastic Process]
   861   C1533592:MALIGNANT [Neoplastic Process]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.134: Their medical records revealed no history of dementia or other psychiatric or neurological diseases. 

Phrase: "Their medical records"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0025102:Medical Records [Intellectual Product]
  1000   C0551625:Medical records [Clinical Attribute]
  1000   C1554096:Medical records [Intellectual Product]
   861   C0034869:Records [Intellectual Product]
   861   C0205476:Medical [Functional Concept]
   861   C1548330:Records [Idea or Concept]
   861   C1553414:Records [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no history of dementia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C0332122:No history of [Qualitative Concept]
   909   C0455499:History of - dementia [Finding]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "or"

Phrase: "other psychiatric"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205487:Psychiatric [Functional Concept]
   928 E C0033872:Psychiatry [Professional or Occupational Group]
   928 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "or"

Phrase: "neurological diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.135: Post-mortem examination revealed no macroscopic infarcts, and all brains scored four or lower on the histopathological scoring system (see above). 

Phrase: "Post-mortem examination"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0004398:Post-Mortem Examination [Diagnostic Procedure]
           postmortem
   901   C0580205:Postmortem [Temporal Concept]
   901   C0848632:post mortem [Finding]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no macroscopic infarcts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021308:INFARCTS [Pathologic Function]
   777 E C0333541:Infarcted [Functional Concept]

Phrase: "and"

Phrase: "all brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "or"

Phrase: "lower on the histopathological scoring system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.136: All autopsy cases (AD and control) were matched by age-at-death and all clinically diagnosed AD cases and healthy volunteers were matched by age-at-onset/age-at-exam, respectively. 

Phrase: "All autopsy cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0004398:Autopsy [Diagnostic Procedure]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(AD"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "matched by age-at-death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1543138:Age at death [Clinical Attribute]
   862   C1546180:Age at death [Clinical Attribute]
   797   C0742983:age death [Finding]
   760   C0001779:Age [Organism Attribute]
   760   C0011065:Death [Organism Function]
   760   C0150103:matched [Research Activity]
   760   C1306577:Death, NOS [Finding]
   760   C1708943:Matched [Qualitative Concept]

Phrase: "and"

Phrase: "all clinically"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "healthy volunteers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1708335:Healthy Volunteers [Population Group]
   861   C0042960:Volunteers [Professional or Occupational Group]
   827 E C1549078:Volunteer [Idea or Concept]
   827 E C1997894:volunteer [Population Group]

Phrase: "were"

Phrase: "matched by age-at-onset/age-at-exam,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0206132:Onset Age [Quantitative Concept]
   744   C0001779:Age [Organism Attribute]
   744   C0150103:matched [Research Activity]
   744   C0332162:Onset [Qualitative Concept]
   744   C0582103:Exam [Health Care Activity]
   744   C1708943:Matched [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.137: Swedish controls for set C consisted of 326 individuals from the Swedish Twin Registry. 

Phrase: "Swedish controls for set C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "consisted of 326 individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "from the Swedish Twin Registry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034975:Registry [Intellectual Product]
Processing 00000000.tx.138: All 80-year-old and older twin pairs in Sweden, where both co-twins were still alive were recruited to participate in the OCTO-Twin study. 

Phrase: "All 80-year-old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "and"

Phrase: "older twin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041427:Twin [Family Group]
   861   C0205173:Twin [Functional Concept]

Phrase: "pairs in Sweden,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038995:Sweden [Geographic Area]
   790   C1709450:Pair [Qualitative Concept]

Phrase: "where"

Phrase: "both co-twins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041427:Twins [Family Group]
   827 E C0205173:Twin [Functional Concept]

Phrase: "were"

Phrase: "still alive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376558:Alive [Idea or Concept]
   861   C2584946:Alive [Finding]

Phrase: "were"

Phrase: "recruited"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in the OCTO-Twin study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282476:twin study [Research Activity]
   790   C1096782:Twin Study [Intellectual Product]
   753   C0041427:Twin [Family Group]
   753   C0205173:Twin [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.139: All participants underwent a thorough health examination, structured interviews/tests of functional capacity, cognitive abilities and memory. 

Phrase: "All participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "underwent"

Phrase: "a thorough health examination,"

Phrase: "structured interviews/tests of functional capacity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0022885:Tests [Laboratory Procedure]
   753   C0392366:Tests [Intellectual Product]
   719 E C0039593:Test [Functional Concept]

Phrase: "cognitive abilities"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0392334:Cognitive ability [Mental Process]
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.140: The preliminary diagnosis was made on the basis of performance on a battery of tests for dementia and cognitive impairment, including MMSE. 

Phrase: "The preliminary diagnosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0332134:Preliminary diagnosis [Qualitative Concept]
  1000   C1716046:Preliminary diagnosis [Clinical Attribute]
   861   C0011900:Diagnosis [Finding]
   861   C0439611:Preliminary [Temporal Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made on the basis of performance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0597198:Performance [Individual Behavior]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
   753   C1882330:Performance [Activity]
   719   C1881534:Make [Functional Concept]

Phrase: "on a battery of tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "for dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cognitive impairment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MMSE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451306:MMSE [Diagnostic Procedure]
  1000   C3538742:MMSE [Intellectual Product]
Processing 00000000.tx.141: Further tests were selected to sample across diverse specific cognitive abilities, including verbal, spatial, speed of processing and memory abilities. 

Phrase: "Further tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sample across diverse specific cognitive abilities,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C0392334:Cognitive ability [Mental Process]
   753   C0085732:Abilities [Organism Attribute]
   753   C0205369:Specific [Qualitative Concept]
   753   C0370003:Sample [Substance]
   753   C1516691:Cognitive [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1880371:Diverse [Qualitative Concept]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "verbal, spatial, speed of processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0582591:Processing speed [Mental Process]
   760   C0678536:Speed [Quantitative Concept]

Phrase: "and"

Phrase: "memory abilities."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]
Processing 00000000.tx.142: A dementia work-up was performed in all cases suspected for dementia and in those demonstrating significant cognitive decline. 

Phrase: "A dementia work-up"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0750430:Work-up [Diagnostic Procedure]
   827   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "performed in all cases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "suspected for dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0332147:Suspected [Qualitative Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C0750491:Suspected [Idea or Concept]
   756 E C1571873:Suspect [Idea or Concept]

Phrase: "and in those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "demonstrating"

Phrase: "significant cognitive decline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.143: Control subjects chosen showed no symptoms of cognitive decline. 

Phrase: "Control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no symptoms of cognitive decline."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0231221:NO SYMPTOMS [Finding]
   797   C0525041:Cognitive Symptoms [Sign or Symptom]
   760   C0683368:symptoms [Functional Concept]
   760   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.144: One sibling, randomly chosen from each twin pair, was included in this control sample. 

Phrase: "One sibling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037047:Sibling [Family Group]
   861   C1611273:Sibling [Intellectual Product]

Phrase: "randomly"

Phrase: "chosen from each twin pair,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0041427:Twin [Family Group]
   760   C0205173:Twin [Functional Concept]
   760   C1707391:Chosen [Activity]
   760   C1709450:Pair [Qualitative Concept]

Phrase: "was"

Phrase: "included in this control sample."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0243148:control [Qualitative Concept]
   760   C0332257:included [Functional Concept]
   760   C0370003:Sample [Substance]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2347026:Sample [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.145: The Scottish EOAD sample (set B) consisted of 121 consecutively ascertained presenile (<65 years) dementia patients from the Lothian Psychiatric Case Register assessed by the NINCDS criteria as possible or probable AD. 

Phrase: "The Scottish EOAD sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "consisted of 121 consecutively ascertained presenile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "("

Phrase: "<65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "dementia patients from the Lothian Psychiatric Case Register"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0585825:patients register [Functional Concept]
   767   C0748064:psychiatric patients [Patient or Disabled Group]
   750 E C1549593:Psychiatric patient [Intellectual Product]
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "assessed by the NINCDS criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243161:criteria [Intellectual Product]
   760   C1516048:Assessed [Activity]

Phrase: "as possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "or"

Phrase: "probable AD."
Processing 00000000.tx.146: Scottish controls for set B consisted of 152 local church congregation volunteers from the Lothian region who met the MMSE exclusion criteria for dementia. 

Phrase: "Scottish controls for set B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "consisted of 152 local church congregation volunteers"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0042960:Volunteers [Professional or Occupational Group]
   748   C0205276:Local [Spatial Concept]
   748   C0562324:Church [Manufactured Object]
   714   C0332529:CONSIST [Qualitative Concept]
   714 E C1549078:Volunteer [Idea or Concept]
   714 E C1997894:volunteer [Population Group]

Phrase: "from the Lothian region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "who"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the MMSE exclusion criteria for dementia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680251:Exclusion Criteria [Functional Concept]
   753   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.147: The EOAD materials were selected from non-familial cases, and the most common presenilin-I mutations have been screened for. 

Phrase: "The EOAD materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "were"

Phrase: "selected from non-familial cases,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1518422:Non [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   726   C1707391:Select [Activity]

Phrase: "and"

Phrase: "the most common presenilin-I mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C1512796:Mutations, Insertion [Genetic Function]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "screened for."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0220908:screen [Health Care Activity]
   799   C1305399:screen [Functional Concept]
   799   C1705053:Screen [Medical Device]
Processing 00000000.tx.148: The few positives found were discarded from the test set. 

Phrase: "The few positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "discarded from the test set."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0022885:Test [Laboratory Procedure]
   760   C0036849:Set [Mental Process]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.149: The English casecontrol group (set D) consisted of 335 autopsy confirmed cases of sporadic AD where 273 had a single diagnosis of AD and the remainder were cases with a primary diagnoses of AD with either concurrent vascular dementia pathology (n=35) or dementia of the Lewy body type (n=26). 

Phrase: "The English casecontrol group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "(set D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: ")"

Phrase: "consisted of 335 autopsy confirmed cases of sporadic AD where 273"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   738   C0004398:Autopsy [Diagnostic Procedure]
   738   C0205422:Sporadic [Temporal Concept]
   738   C0521093:confirmed [Qualitative Concept]
   738   C0750484:Confirmed [Idea or Concept]
   738   C0868928:Cases [Functional Concept]
   738   C1533148:Cases [Quantitative Concept]
   704   C0332529:CONSIST [Qualitative Concept]
   704 E C1456348:Confirm [Qualitative Concept]
   704 E C1706255:CASE [Medical Device]
   704 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "a single diagnosis of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "the remainder"

Phrase: "were"

Phrase: "cases with a primary diagnoses of AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "with either concurrent vascular dementia pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0030664:Pathology [Biomedical Occupation or Discipline]
   804   C0205469:pathology [Functional Concept]
   804   C0677042:pathology [Pathologic Function]
   733 E C1521733:Pathologic [Functional Concept]

Phrase: "(n=35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "dementia of the Lewy body type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0752347:Dementia of the Lewy body type [Disease or Syndrome]
           Dementia, Lewy Body
   820   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(n=26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.150: A total of 110 age-matched elderly controls were also used which had no previous clinical evidence of memory impairment and were confirmed at autopsy for the absence of any memory impairment-related pathology. 

Phrase: "A total of 110 age-matched elderly controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "had"

Phrase: "no previous clinical evidence of memory impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "were"

Phrase: "confirmed at autopsy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "for the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any memory impairment-related pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.151: The DNA used in this set was extracted from donated brain tissue from both the South West Brain Bank in Bristol (252 AD; 58 controls) and the MRC Brain bank in London (83 AD; 52 controls) and the work was carried out with Local Research Ethics Committee knowledge and approval. 

Phrase: "The DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used in this set"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0036849:Set [Mental Process]
   770   C1273517:used [Finding]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "extracted from donated brain tissue"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0440746:Brain tissue [Tissue]
   806   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   797   C0425263:donated tissue [Finding]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1547928:Tissue [Intellectual Product]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "from both"

Phrase: "the South West Brain Bank in Bristol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0282246:West Bank [Geographic Area]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]

Phrase: "(252 AD"

Phrase: "; 58 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the MRC Brain bank in London"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]

Phrase: "(83 AD"

Phrase: "; 52 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with Local Research Ethics Committee knowledge"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0086911:Research Ethics Committee [Professional or Occupational Group]
   778   C0085546:Ethics Committee [Professional or Occupational Group]
   778   C0814851:Ethics, Research [Idea or Concept]
   748   C0015000:Ethics [Idea or Concept]
   748   C0035168:research [Research Activity]
   748   C0205276:Local [Spatial Concept]
   748   C0242481:Research [Research Activity]
   748   C0376554:Knowledge [Intellectual Product]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1527243:ethics [Idea or Concept]
   748   C2699414:Committee [Group]

Phrase: "and"

Phrase: "approval."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205540:Approval [Qualitative Concept]
  1000   C2346845:Approval [Intellectual Product]
Processing 00000000.tx.152: All neuropathological confirmations were assessed by an experienced neuropathologist and diagnosed according to the CERAD criteria. 

Phrase: "All neuropathological confirmations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521091:confirmations [Qualitative Concept]
   827 E C0750484:Confirmation [Idea or Concept]

Phrase: "were"

Phrase: "assessed by an experienced neuropathologist"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0334903:Neuropathologist [Professional or Occupational Group]
   760   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "diagnosed according to the CERAD criteria."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   750   C0002395:Alzheimer's Disease [Disease or Syndrome]
   750   C1521724:Alzheimer's Disease [Pathologic Function]
   749   C0920465:disease registry [Intellectual Product]
   735   C0011900:Diagnosed [Finding]
   735   C0012634:Disease [Disease or Syndrome]
   735   C0034975:Registry [Intellectual Product]
   735   C0243161:criteria [Intellectual Product]
   735   C0443211:establish [Qualitative Concept]
   735   C0680240:according [Social Behavior]
   735   C1513822:Consortium [Professional or Occupational Group]
   735   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.153: A total of 40 individuals diagnosed with AD were included in this set that had previously been reported on for the Alu indel polymorphism (36). 

Phrase: "A total of 40 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "diagnosed with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011900:Diagnosed [Finding]

Phrase: "were"

Phrase: "included in this set"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0036849:Set [Mental Process]
   770   C0332257:included [Functional Concept]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "that"

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "reported on"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0684224:Reported [Intellectual Product]
   833   C0700287:Reported [Health Care Activity]
   833   C3496591:Reported [Clinical Attribute]
   799 E C3273238:Report [Intellectual Product]

Phrase: "for the Alu indel polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.154: Set E consisted of 1526 healthy controls. 

Phrase: "Set E"

Phrase: "consisted of 1526 healthy controls."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2986479:Healthy Control [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.155: This material constitutes the control group of participants in the Stockholm Heart Epidemiology Program (SHEEP), a population-based casecontrol study aimed to investigate the effects of different risk factors for myocardial infarction in men and women. 

Phrase: "This material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "constitutes"

Phrase: "the control group of participants"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in the Stockholm Heart Epidemiology Program (SHEEP),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "a population-based casecontrol study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0007328:Case-Control Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of different risk factors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "for myocardial infarction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.156: In this sub-set of SHEEP, only controls originally matched to surviving cases were included. 

Phrase: "In this sub-set"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0036849:Set [Mental Process]
   861   C0542339:Sub- [Spatial Concept]
   861   C1264637:SUB [Quantitative Concept]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of SHEEP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "originally"

Phrase: "matched to surviving cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0150103:matched [Research Activity]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1708943:Matched [Qualitative Concept]
   737   C0310255:SURVIVE [Pharmacologic Substance]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.157: More detailed demographic characteristics of these control subjects (i.e. who had not suffered a myocardial infraction) were reported elsewhere (37). 

Phrase: "More"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "demographic characteristics of these control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0683970:demographic characteristics [Group Attribute]
   767   C0681884:subject characteristics [Research Activity]
   767   C1519021:Subject Characteristics [Organism Attribute]
   767   C1706465:Subject Characteristics [Idea or Concept]
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "who"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683278:suffered [Mental or Behavioral Dysfunction]

Phrase: "a myocardial infraction"

Phrase: ")"

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "elsewhere"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.158: The subjects were aged 4570 and were selected from the Stockholm County population registry. 

Phrase: "The subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "4570"

Phrase: "and"

Phrase: "were"

Phrase: "selected from the Stockholm County population registry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032659:Population [Quantitative Concept]
   748   C0034975:Registry [Intellectual Product]
   748   C0079170:County [Geographic Area]
   748   C1257890:Population [Population Group]
   714   C1707391:Select [Activity]
Processing 00000000.tx.159: CSF A42 measurement Cerebrospinal fluid levels of A42 were estimated in a subset of individuals from sets A and C. 

Phrase: "CSF A42 measurement Cerebrospinal fluid levels of A42"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   793   C0007806:CSF - Cerebrospinal fluid [Body Substance]
           Cerebrospinal Fluid
   770   C0007807:cerebrospinal fluid [Functional Concept]
   744   C0005889:FLUID [Body Substance]
   744   C0302908:fluid [Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1704353:Fluid [Substance]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "estimated in a subset of individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0750572:Estimated [Quantitative Concept]
   753   C1515021:Subset [Classification]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "from"

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.160: For this, lumbar puncture was performed at the L3/L4 or L4/L5 interface. 

Phrase: "For this,"

Phrase: "lumbar puncture"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0037943:Lumbar Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C0553794:Lumbar puncture, NOS [Diagnostic Procedure]
  1000   C1548878:Lumbar Puncture [Health Care Activity]
   861   C0024090:Lumbar [Body Location or Region]
   861   C0033119:Puncture [Finding]
   861   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "was"

Phrase: "performed at the L3/L4"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0884358:Performed [Functional Concept]
   760   C1179700:L3 [Body Location or Region]
   760   C1419655:L3 [Gene or Genome]
   760   C1419676:L4 [Gene or Genome]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "L4/L5 interface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708533:Interface [Manufactured Object]
   827   C2698172:Interface [Intellectual Product]
Processing 00000000.tx.161: The first 12ml of CSF was collected in polypropylene tubes and gently mixed to avoid gradient effects. 

Phrase: "The first 12ml of CSF"

Phrase: "was"

Phrase: "collected in polypropylene tubes"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0032582:Polypropylene [Biomedical or Dental Material,Organic Chemical]
   770   C0175730:tubes [Medical Device]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "gradient effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.162: All CSF samples with erythrocyte counts of more than 500/l were excluded. 

Phrase: "All CSF samples with erythrocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "counts of more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439157:counts [Quantitative Concept]
   790   C0750480:Count [Activity]
   790   C1705566:Count [Quantitative Concept]

Phrase: "than 500/l"

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.163: CSF samples were centrifuged at 2000g for 10min. 

Phrase: "CSF samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 2000g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 10min."
Processing 00000000.tx.164: Aliquots were stored at -80C until biochemical analyses were performed. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C until biochemical analyses"

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.165: A42 was determined using a sandwich ELISA specific for A42, as previously described (25). 

Phrase: "A42"

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a sandwich ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "specific for A42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.166: SNP selection and verification All reported SNPs may be found in the dbSNP database (www.ncbi.nlm.nih.gov/SNP/) under their respective IDs (Table 2). 

Phrase: "SNP selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "verification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237944:Verification [Research Activity]
  1000   C1711411:Verification [Functional Concept]

Phrase: "All"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "found in the dbSNP database"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0150312:Found [Quantitative Concept]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1710090:dbSNP [Intellectual Product]
   726 E C0243095:Find [Finding]

Phrase: "(www.ncbi.nlm.nih.gov/SNP/)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0752046:SNP [Nucleotide Sequence]
   799   C1527094:SNP [Conceptual Entity]

Phrase: "under their respective IDs (Table 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0039224:Table [Manufactured Object]
   812   C1706073:Table [Medical Device]
   812   C1706074:Table [Intellectual Product]
   729   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: ")."
Processing 00000000.tx.167: Surrounding 50bp sequences in each direction were examined for repeats and duplicated sequences using Repeatmasker (http://repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker/) and Blast (www.ncbi.nlm.nih.gov/blast). 

Phrase: "Surrounding 50bp"

Phrase: "sequences in each direction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0449738:Direction [Spatial Concept]
   770   C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "examined for repeats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205341:repeats [Functional Concept]
   790   C0332128:Examined [Finding]
   790   C1705914:Repeats [Conceptual Entity]
   756 E C1547730:Repeat [Temporal Concept]

Phrase: "and"

Phrase: "duplicated sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Repeatmasker"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker/"

Phrase: ")"

Phrase: "and"

Phrase: "Blast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337026:Blast [Natural Phenomenon or Process]
  1000   C0368761:blast [Cell]

Phrase: "(www.ncbi.nlm.nih.gov/blast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0337026:Blast [Natural Phenomenon or Process]
   799   C0368761:blast [Cell]

Phrase: ")."
Processing 00000000.tx.168: To verify that SNPs were polymorphic in our study populations, each was tested in a set of 16 Swedish control samples. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "polymorphic in our study populations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882417:Polymorphic [Qualitative Concept]

Phrase: "each"

Phrase: "was"

Phrase: "tested in a set of 16 Swedish control samples."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   745   C1272570:Test control [Indicator, Reagent, or Diagnostic Aid]
   742   C0036849:Set [Mental Process]
   742   C0243148:control [Qualitative Concept]
   742   C0392366:tested [Intellectual Product]
   742   C1442518:Set [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1705195:Set [Conceptual Entity]
   742   C1710263:Swedish [Population Group]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.169: Assays in which all 16 samples were monomorphic were excluded from further analysis. 

Phrase: "Assays in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "all 16 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "monomorphic"

Phrase: "were"

Phrase: "excluded from further analysis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0205108:far [Spatial Concept]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.170: For the rare previously identified non-synonymous SNPs, 95 controls were used. 

Phrase: "For the rare previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521114:Rare [Temporal Concept]
   861   C0522498:Rare [Qualitative Concept]
   861   C1514917:RARE [Gene or Genome]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "non-synonymous SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "95 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.171: All SNPs that were polymorphic in the Swedish population were also found to be polymorphic in the Scottish population. 

Phrase: "All SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "polymorphic in the Swedish population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882417:Polymorphic [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "polymorphic in the Scottish population."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882417:Polymorphic [Qualitative Concept]
Processing 00000000.tx.172: Genotyping Genotyping of SNPs was performed using dynamic allele specific hybridization (DASH) (38). 

Phrase: "Genotyping Genotyping of SNPs"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dynamic allele specific hybridization (DASH)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.173: Optimal PCR temperatures as well as sequences for PCR primers and iFRET probes are shown in Table 2. 

Phrase: "Optimal PCR temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0039476:Temperatures [Quantitative Concept]
   793 E C0005903:temperature [Organism Attribute]

Phrase: "as well as"

Phrase: "sequences for PCR primers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0677874:pCR [Finding]
   770   C1519249:Sequence [Functional Concept]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "iFRET probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "are"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: All PCR reactions were run in 20l volumes with 1.5mM MgCl2 and using 520ng genomic DNA. 

Phrase: "All PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "run in 20l volumes with 1.5mM MgCl2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0449468:volumes [Quantitative Concept]
   711 E C1690016:% volume [Qualitative Concept]
   711 E C1705102:Volume [Intellectual Product]
   711 E C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "520ng genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.175: Statistical analysis Deviation from HardyWeinberg equilibrium for alleles at individual loci as well as differences in genotype and haplotype distributions between groups were assessed by the chi-square statistic. 

Phrase: "Statistical analysis Deviation from HardyWeinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012727:Deviation [Spatial Concept]
   753   C0205419:Deviation [Qualitative Concept]
   753   C1705236:Deviation [Finding]

Phrase: "for alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "at individual loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "as well as"

Phrase: "differences in genotype"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "haplotype distributions between groups"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0037775:Distributions [Spatial Concept]
   737 E C0520511:distribution [Idea or Concept]
   737 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "assessed by the chi-square statistic."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1552646:chi square [Quantitative Concept]
   753   C0205120:Square [Spatial Concept]
   753   C1516048:Assessed [Activity]
   753   C1552595:Square [Intellectual Product]
   753   C1720589:Chi [Intellectual Product]
   753   C2348149:Statistic [Quantitative Concept]
   753   C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.176: Tests for association between haplotypes and CSF A42 levels were performed using analysis of variance (ANOVA), and significant findings were further assessed using KruskalWallis analysis of ranks. 

Phrase: "Tests for association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   756 E C0039593:Test [Functional Concept]

Phrase: "between haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "CSF A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "analysis of variance (ANOVA),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "significant findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "KruskalWallis analysis of ranks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.177: Confounding effects of duration, age-at-assessment or sex were evaluated by including each term as a covariate in ANOVA models. 

Phrase: "Confounding effects of duration,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "age-at-assessment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0846606:age assessment [Health Care Activity]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]

Phrase: "or"

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "were"

Phrase: "evaluated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0220825:Evaluated [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "each term as a covariate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "in ANOVA models."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   884   C0002780:Analysis of Variance [Quantitative Concept]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0150312:In [Quantitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   804   C1711260:Variance [Qualitative Concept]
   804   C2348152:Variance [Quantitative Concept]
   804   C3161035:Models [Intellectual Product]
   733 E C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.178: All of the above statistical analyses were performed using StatView version 5.0 (Abacus Concepts). 

Phrase: "All of the above statistical analyses"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0871424:statistical analysis [Research Activity]
   753   C0038215:Statistical [Occupation or Discipline]
   753   C0444868:All [Quantitative Concept]
   753   C3539085:All [Idea or Concept]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "StatView version 5.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: "(Abacus Concepts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concepts [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.179: Meta-analyses were performed using Peto's method (24). 

Phrase: "Meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0920317:meta-analyses [Research Activity]
   966 E C0282458:Meta-Analysis [Intellectual Product]
   861   C1042496:Meta [Eukaryote]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Peto's method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452238:Peto method [Therapeutic or Preventive Procedure]
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.180: Haplotype frequencies were estimated using the HAPLOTYPER program (21). 

Phrase: "Haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HAPLOTYPER program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.181: LD between marker pairs within ACE was estimated using the r2 metric (23). 

Phrase: "LD between marker"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "pairs within ACE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   882   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   790   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1709450:Pair [Qualitative Concept]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the r2"

Phrase: "metric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699680:Metric [Organic Chemical,Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.182: Population attributable risk was calculated under a dominant model for the ACE6 marker (28).  

Phrase: "Population attributable risk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1514229:Population Attributable Risk [Quantitative Concept]
   913   C0242444:population risk [Population Group]
   913   C2987720:Population risk [Quantitative Concept]
   901   C0814766:Attributable Risk [Qualitative Concept]
   827   C0032659:Population [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C0596130:Attributable [Mental Process]
   827   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "calculated under a dominant model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1527180:Dominant [Functional Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "for the ACE6 marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.183: ACKNOWLEDGEMENTS  Generous financial support was provided by: Pharmacia Corporation, Loo and Hans Ostermans Foundation, The Knut and Alice Wallenberg Foundation, The National Institute on Aging (AG:08861), The Swedish Old Servants Foundation (Gamla Tjnarinnor), ke Wibergs Foundation, Torsten and Ragnar Sderbergs Foundation, Fredrik and Ingrid Thurings Foundation, King Gustav the Vth and Queen Victoria's Foundation, The Swedish Heart and Lung Foundation, Petrus and Augusta Hedlunds Foundation, and The Swedish Alzheimer Foundation (Alzheimerfonden).  

Phrase: "ACKNOWLEDGEMENTS  Generous financial support"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0016118:Financial Support [Idea or Concept]
   812   C0183683:Support [Medical Device]
   812   C0376243:financial [Quantitative Concept]
   812   C1521721:Support [Conceptual Entity]
   812   C2350008:Financial [Qualitative Concept]

Phrase: "was"

Phrase: "provided by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1999230:Provided [Activity]

Phrase: ":"

Phrase: "Pharmacia Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Loo"

Phrase: "and"

Phrase: "Hans Ostermans Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "The Knut"

Phrase: "and"

Phrase: "Alice Wallenberg Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "The National Institute on Aging"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "(AG:08861"

Phrase: ")"

Phrase: ","

Phrase: "The Swedish Old Servants Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "(Gamla Tjnarinnor"

Phrase: ")"

Phrase: ","

Phrase: "ke Wibergs Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "Torsten"

Phrase: "and"

Phrase: "Ragnar Sderbergs Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "Fredrik"

Phrase: "and"

Phrase: "Ingrid Thurings Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "King Gustav"

Phrase: "the Vth"

Phrase: "and"

Phrase: "Queen Victoria's Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "The Swedish Heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Lung Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   958   C0225704:lung base [Body Part, Organ, or Organ Component]
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "Petrus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1057451:Petrus [Fish]

Phrase: "and"

Phrase: "Augusta Hedlunds Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "The Swedish Alzheimer Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "(Alzheimerfonden"

Phrase: ")."
Processing 00000000.tx.184: FOOTNOTES  * To whom correspondence should be addressed at: Center for Genomics and Bioinformatics, Karolinska Institute, Berzeliusvg 35, 171 77 Stockholm, Sweden. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Center for Genomics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Berzeliusvg 35,"

Phrase: "171 77 Stockholm,"

Phrase: "Sweden."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]
Processing 00000000.tx.185: Tel: +46 87286274; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+46 87286274"

Phrase: ";"
Processing 00000000.tx.186: Fax: +46 8324826; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+46 8324826"

Phrase: ";"
Processing 00000000.tx.187: Email: Jonathan.Prince{at}cgb.ki.se  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "Jonathan.Prince{at}cgb.ki.se"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L. et al."
Processing 00000000.tx.188: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.189: Nature, 349, 704706.[CrossRef][ISI][Medline] Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704706."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.190: G., Holman, K. et al. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K. et al."
Processing 00000000.tx.191: (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.192: Nature, 375, 754760.[CrossRef][ISI][Medline] Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754760."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T. et al."
Processing 00000000.tx.193: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.194: Nature, 376, 775778.[CrossRef][ISI][Medline] Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775778."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strittmatter,"

Phrase: "W.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schmechel,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]
Processing 00000000.tx.195: (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "high-avidity binding to beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1149161:beta-amyloid binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimer disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.196: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.197: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.198: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.199: USA, 90, 19771981.[Abstract] Haines, J.L., Bailey, L.R., Grubber, J.M., Hedges, D., Hall, J.L., West, S., Santoro, L., Kemmerer, B., Saunders, A.M., Roses, A.D. et al. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "19771981."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Haines,"

Phrase: "J.L., Bailey,"

Phrase: "L.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Grubber,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Hedges,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Hall,"

Phrase: "J.L., West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705493:West [Spatial Concept]

Phrase: "S."

Phrase: ","

Phrase: "Santoro,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kemmerer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D. et al."
Processing 00000000.tx.200: (2001) A genomic screen for Alzheimer's Disease genes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A genomic screen for Alzheimer's Disease genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220908:screen [Health Care Activity]
   748   C1305399:screen [Functional Concept]
   748   C1705053:Screen [Medical Device]
Processing 00000000.tx.201: In Iqbal K., Sidsodia S.S., Winblad, B. 

Phrase: "In Iqbal K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sidsodia S.S.,"

Phrase: "Winblad,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.202: (eds), Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "Advances in Etiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0725066:Advance [Medical Device]

Phrase: "Pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "Therapeutics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.203: J Wiley, New York, pp. 

Phrase: "J Wiley,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp."
Processing 00000000.tx.204: 3343. 

Phrase: "3343."
Processing 00000000.tx.205: Terwilliger, J.D. and Weiss, K.M. 

Phrase: "Terwilliger,"

Phrase: "J.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "Weiss,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.206: (1998) Linkage disequilibrium mapping of complex disease: fantasy or reality? 

Phrase: "(1998"

Phrase: ")"

Phrase: "Linkage disequilibrium mapping of complex disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   783   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1283195:Mapping [Activity]

Phrase: ":"

Phrase: "fantasy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015630:Fantasy [Mental Process]

Phrase: "or"

Phrase: "reality?"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0871222:reality [Idea or Concept]
   928 E C0237400:Real [Qualitative Concept]
   928 E C3272377:REAL [Intellectual Product]
Processing 00000000.tx.207: Curr. 

Phrase: "Curr."
Processing 00000000.tx.208: Opin. 

Phrase: "Opin."
Processing 00000000.tx.209: Biotechnol., 9, 578594.[CrossRef][ISI][Medline] Pritchard, J.K. and Cox, N.J. 

Phrase: "Biotechnol.,"

Phrase: "9,"

Phrase: "578594."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pritchard,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Cox,"

Phrase: "N.J."
Processing 00000000.tx.210: (2002) The allelic architecture of human disease genes: common disease-common variant or not? 

Phrase: "(2002"

Phrase: ")"

Phrase: "The allelic architecture of human disease genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003737:Architecture [Occupation or Discipline]

Phrase: ":"

Phrase: "common disease-common variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "or"

Phrase: "not?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.211: Hum. 

Phrase: "Hum."
Processing 00000000.tx.212: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.213: Genet., 11, 24172423.[Abstract/Free FullText] Steinmetz, L.M., Sinha, H., Richards, D.R., Spiegelman, J.I., Oefner, P.J., McCusker, J.H. and Davis, R.W. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "24172423."

Phrase: "[Abstract/Free FullText"

Phrase: "] Steinmetz,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Sinha,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Richards,"

Phrase: "D.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Spiegelman,"

Phrase: "J.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "Oefner,"

Phrase: "P.J.,"

Phrase: "McCusker,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Davis,"

Phrase: "R.W."
Processing 00000000.tx.214: (2002) Dissecting the architecture of a quantitative trait locus in yeast. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Dissecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:Dissecting [Functional Concept]

Phrase: "the architecture of a quantitative trait locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003737:Architecture [Occupation or Discipline]

Phrase: "in yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.215: Nature, 416, 326330.[CrossRef][ISI][Medline] Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "416,"

Phrase: "326330."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Altshuler,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Hirschhorn,"

Phrase: "J.N., Klannemark,"

Phrase: "M."

Phrase: ","

Phrase: "Lindgren,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Vohl,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nemesh,"

Phrase: "J.,"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "C.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schaffner,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Bolk,"

Phrase: "S."

Phrase: ","

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "C. et al."
Processing 00000000.tx.216: (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The common PPARgamma Pro12Ala polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased risk of type 2 diabetes."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441730:Type 2 [Classification]
   767   C1171304:diabetes risk [Quantitative Concept]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.217: Nat. 

Phrase: "Nat."
Processing 00000000.tx.218: Genet., 26, 7680.[CrossRef][ISI][Medline] Meijers-Heijboer, H., Van Den Ouweland, A., Klijn, J., Wasielewski, M., De Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen M. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "26,"

Phrase: "7680."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meijers-Heijboer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van Den Ouweland,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "A.,"

Phrase: "Klijn,"

Phrase: "J.,"

Phrase: "Wasielewski,"

Phrase: "M."

Phrase: ","

Phrase: "De Snoo,"

Phrase: "A.,"

Phrase: "Oldenburg,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hollestelle,"

Phrase: "A.,"

Phrase: "Houben,"

Phrase: "M."

Phrase: ","

Phrase: "Crepin,"

Phrase: "E.,"

Phrase: "van Veghel-Plandsoen M. et al."
Processing 00000000.tx.219: (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Low-penetrance susceptibility to breast cancer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "due to CHEK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1259236:CHEK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1424448:CHEK2 [Gene or Genome]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: "1100delC in noncarriers of BRCA1"

Phrase: "or"

Phrase: "BRCA2 mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1511024:BRCA2 Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.220: Nat. 

Phrase: "Nat."
Processing 00000000.tx.221: Genet., 31, 5559.[CrossRef][ISI][Medline] Hugot, J.P., Chamaillard, M., Zouali. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "5559."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hugot,"

Phrase: "J.P.,"

Phrase: "Chamaillard,"

Phrase: "M."

Phrase: ","

Phrase: "Zouali."
Processing 00000000.tx.222: H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lesage,"

Phrase: "S."

Phrase: ","

Phrase: "Cezard,"

Phrase: "J.P.,"

Phrase: "Belaiche,"

Phrase: "J.,"

Phrase: "Almer,"

Phrase: "S."

Phrase: ","

Phrase: "Tysk,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "O'Morain,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Gassull,"

Phrase: "M. et al."
Processing 00000000.tx.223: (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Association of NOD2 leucine-rich repeat variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Crohn's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0010346:Crohn Disease [Disease or Syndrome]
           Crohn's
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.224: Nature, 411, 599603.[CrossRef][ISI][Medline] Weiss, K.M. and Clark, A.G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "411,"

Phrase: "599603."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weiss,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Clark,"

Phrase: "A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.225: (2002) Linkage disequilibrium and the mapping of complex human traits. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "the mapping of complex human traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]
Processing 00000000.tx.226: Trends Genet., 18, 1924.[CrossRef][ISI][Medline] Akey, J., Jin, L. and Xiong, M. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "1924."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akey,"

Phrase: "J.,"

Phrase: "Jin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Xiong,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.227: (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? 

Phrase: "(2001"

Phrase: ")"

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "vs"

Phrase: "single marker linkage disequilibrium tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0022885:Tests [Laboratory Procedure]
   804   C0392366:Tests [Intellectual Product]
   771 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "what"

Phrase: "do"

Phrase: "we"

Phrase: "gain?"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.228: Eur. 

Phrase: "Eur."
Processing 00000000.tx.229: J. 

Phrase: "J."
Processing 00000000.tx.230: Hum. 

Phrase: "Hum."
Processing 00000000.tx.231: Genet., 9, 291300.[CrossRef][ISI][Medline] Lehmann, D.J., Williams, J., McBroom, J. and Smith, A.D. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "291300."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lehmann,"

Phrase: "D.J.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "McBroom,"

Phrase: "J."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]
Processing 00000000.tx.232: (2001) Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "meta-analysis to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "explain"

Phrase: "the diversity of results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "in genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "high-risk subgroups."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]
Processing 00000000.tx.233: Neuroscience, 105, 541554. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "105,"

Phrase: "541554."
Processing 00000000.tx.234: Narain, Y., Yip, A., Murphy, T., Brayne, C., Easton, D., Evans, J.G., Xuereb, J., Cairns, N., Esiri, M.M., Furlong, R.A. et al. 

Phrase: "Narain,"

Phrase: "Y.,"

Phrase: "Yip,"

Phrase: "A.,"

Phrase: "Murphy,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Brayne,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Easton,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Evans,"

Phrase: "J.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Xuereb,"

Phrase: "J.,"

Phrase: "Cairns,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Esiri,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Furlong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552921:Furlong [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A. et al."
Processing 00000000.tx.235: (2000) The ACE gene and Alzheimer's disease susceptibility. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The ACE gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease susceptibility."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.236: J. 

Phrase: "J."
Processing 00000000.tx.237: Med. 

Phrase: "Med."
Processing 00000000.tx.238: Genet., 37, 695697.[Abstract/Free FullText] Sanchez-Guerra, M., Combarros, O., Infante, J., Llorca, J., Berciano, J., Fontalba, A., Fernandez-Luna, J.L., Pena, N. and Fernandez-Viadero, C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "695697."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sanchez-Guerra,"

Phrase: "M."

Phrase: ","

Phrase: "Combarros,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Infante,"

Phrase: "J.,"

Phrase: "Llorca,"

Phrase: "J.,"

Phrase: "Berciano,"

Phrase: "J.,"

Phrase: "Fontalba,"

Phrase: "A.,"

Phrase: "Fernandez-Luna,"

Phrase: "J.L., Pena,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Fernandez-Viadero,"

Phrase: "C."
Processing 00000000.tx.239: (2001) Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "of low density lipoprotein receptor-related protein gene exon 3 polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   824   C0678951:gene polymorphism [Genetic Function]
   790   C0032529:Polymorphism [Genetic Function]
   790   C1882417:Polymorphism [Qualitative Concept]
   752   C1416915:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3 [Gene or Genome]
   707   C1366529:Low density lipoprotein receptor gene [Gene or Genome]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.240: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.241: Lett., 316, 1720.[CrossRef][ISI][Medline] Keavney, B., McKenzie, C.A., Connell, J.M., Julier, C., Ratcliffe, P.J., Sobel, E., Lathrop, M. and Farrall, M. 

Phrase: "Lett.,"

Phrase: "316,"

Phrase: "1720."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Keavney,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McKenzie,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Connell,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Julier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ratcliffe,"

Phrase: "P.J.,"

Phrase: "Sobel,"

Phrase: "E.,"

Phrase: "Lathrop,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Farrall,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.242: (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Measured haplotype analysis of the angiotensin-I converting enzyme gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
Processing 00000000.tx.243: Hum. 

Phrase: "Hum."
Processing 00000000.tx.244: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.245: Genet., 7, 17451751.[Abstract/Free FullText] Rieder, M.J., Taylor, S.L., Clark, A.G. and Nickerson, D.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "17451751."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rieder,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Taylor,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Nickerson,"

Phrase: "D."

Phrase: "A."
Processing 00000000.tx.246: (1999) Sequence variation in the human angiotensin converting enzyme. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Sequence variation in the human angiotensin converting enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0042333:Sequence Variation [Natural Phenomenon or Process]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0205419:Variation [Qualitative Concept]
   744   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.247: Nat. 

Phrase: "Nat."
Processing 00000000.tx.248: Genet., 22, 5962.[CrossRef][ISI][Medline] Farrall, M., Keavney, B., McKenzie, C., Delepine, M., Matsuda, F. and Lathrop, G.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "5962."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrall,"

Phrase: "M."

Phrase: ","

Phrase: "Keavney,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McKenzie,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Delepine,"

Phrase: "M."

Phrase: ","

Phrase: "Matsuda,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lathrop,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.249: (1999) Fine-mapping of an ancestral recombination breakpoint in DCP1. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Fine-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205232:Fine [Qualitative Concept]
  1000   C0687757:fine [Regulation or Law]

Phrase: "mapping of an ancestral recombination breakpoint"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0034865:Recombination [Genetic Function]
   753   C1283195:Mapping [Activity]
   719 E C0024779:Map [Manufactured Object]
   719 E C1706473:Map [Conceptual Entity]

Phrase: "in DCP1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022709:Dipeptidyl Carboxypeptidase 1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1413931:DIPEPTIDYL CARBOXYPEPTIDASE 1 [Gene or Genome]
   901   C0058360:dipeptidyl carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3265462:Carboxypeptidase [Pharmacologic Substance]
Processing 00000000.tx.250: Nat. 

Phrase: "Nat."
Processing 00000000.tx.251: Genet., 23, 270271.[CrossRef][ISI][Medline] Hu, J., Igarashi, A., Kamata, M. and Nakagawa, H. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "270271."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "J.,"

Phrase: "Igarashi,"

Phrase: "A.,"

Phrase: "Kamata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nakagawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.252: (2002) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); 

Phrase: "(2002"

Phrase: ")"

Phrase: "Angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "degrades"

Phrase: "Alzheimer amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   923   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "(A beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.253: retards A beta aggregation, deposition, fibril formation; 

Phrase: "retards"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "A beta aggregation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
   734   C1420510:A-BETA [Gene or Genome]

Phrase: "deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: ";"
Processing 00000000.tx.254: and inhibits cytotoxicity. 

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.255: J. 

Phrase: "J."
Processing 00000000.tx.256: Biol. 

Phrase: "Biol."
Processing 00000000.tx.257: Chem., 276, 4786347868. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "4786347868."
Processing 00000000.tx.258: Niu, T., Qin, Z.S., Xu, X. and Liu, J.S. 

Phrase: "Niu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028219:NIU [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "Z.S.,"

Phrase: "Xu,"

Phrase: "X."

Phrase: "and"

Phrase: "Liu,"

Phrase: "J.S."
Processing 00000000.tx.259: (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679201:Inference [Mental Process]
Processing 00000000.tx.260: Am. 

Phrase: "Am."
Processing 00000000.tx.261: J. 

Phrase: "J."
Processing 00000000.tx.262: Hum. 

Phrase: "Hum."
Processing 00000000.tx.263: Genet., 70, 157169.[CrossRef][ISI][Medline] Johnson, G.C., Esposito, L., Barratt, B.J., Smith, A.N., Heward, J., Di Genova, G., Ueda, H., Cordell, H.J., Eaves, I.A., Dudbridge, F. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "70,"

Phrase: "157169."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "G.C., Esposito,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Barratt,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.N., Heward,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1272460:a n [Qualitative Concept]

Phrase: "J.,"

Phrase: "Di Genova,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cordell,"

Phrase: "H.J.,"

Phrase: "Eaves,"

Phrase: "I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "A.,"

Phrase: "Dudbridge,"

Phrase: "F. et al."
Processing 00000000.tx.264: (2001) Haplotype tagging for the identification of common disease genes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Haplotype tagging for the identification of common disease genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0037293:Tag [Neoplastic Process]
   708   C0181496:Tag [Manufactured Object]
   708   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.265: Nat. 

Phrase: "Nat."
Processing 00000000.tx.266: Genet., 29, 233237.[CrossRef][ISI][Medline] Hill, W.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "29,"

Phrase: "233237."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.267: (1974) Estimation of linkage disequilibrium in randomly mating populations. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Estimation of linkage disequilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]

Phrase: "in randomly mating populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.268: Heredity, 33, 229239.[ISI][Medline] Yusuf, S., Peto, R., Lewis, J., Collins, R. and Sleight, P. 

Phrase: "Heredity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019266:Heredity [Molecular Function]
  1000   C0220848:heredity [Biologic Function]

Phrase: "33,"

Phrase: "229239."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yusuf,"

Phrase: "S."

Phrase: ","

Phrase: "Peto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Collins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sleight,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.269: (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Beta blockade during"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0330390:Beta [Plant]
   790   C0332206:Blockade [Functional Concept]
   790   C0439096:Beta [Intellectual Product]
   790   C2004068:Beta [Qualitative Concept]
   790   C3540676:Blockade [Pharmacologic Substance]

Phrase: "and after myocardial infarction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0027051:Myocardial Infarction [Disease or Syndrome]
   833   C0428953:MYOCARDIAL INFARCTION [Finding]
   833   C2926063:Myocardial infarction [Clinical Attribute]
   770   C0021308:Infarction [Pathologic Function]
   770   C0027061:Myocardial [Tissue]
   770   C1515981:And [Idea or Concept]
   770   C1522564:Myocardial [Spatial Concept]

Phrase: ":"

Phrase: "an overview of the randomized trials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814812:overview [Intellectual Product]
Processing 00000000.tx.270: Prog. 

Phrase: "Prog."
Processing 00000000.tx.271: Cardiovasc. 

Phrase: "Cardiovasc."
Processing 00000000.tx.272: Dis., 27, 335371.[ISI][Medline] Andreasen, N., Hesse, C., Davidsson, P., Wallin, A., Minthon, L., Winblad, B., Vanderstichele, H., Vanmechelen, E. and Blennow, K. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "27,"

Phrase: "335371."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Andreasen,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hesse,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davidsson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wallin,"

Phrase: "A.,"

Phrase: "Minthon,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vanmechelen,"

Phrase: "E."

Phrase: "and"

Phrase: "Blennow,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.273: (1999) Cerebrospinal fluid b-amyloid(142) in Alzheimer's disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cerebrospinal fluid b-amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(142"

Phrase: ")"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "differences between early-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "late-onset Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "stability during the course of disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]
   748   C0677946:Stable Disease [Finding]
   748   C3538874:Stable Disease [Finding]
Processing 00000000.tx.274: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.275: Neurol., 56, 673680.[Abstract/Free FullText] Andreasen, N. and Blennow, K. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "673680."

Phrase: "[Abstract/Free FullText"

Phrase: "] Andreasen,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Blennow,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.276: (2002) Beta-Amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Beta-Amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Abeta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420510:A-BETA [Gene or Genome]
  1000   C1705543:ABETA [Gene or Genome]

Phrase: ")"

Phrase: "protein in cerebrospinal fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C0201943:Cerebrospinal fluid protein [Laboratory Procedure]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as a biomarker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Biomarker [Clinical Attribute]

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.277: Peptides, 23, 12051214.[CrossRef][ISI][Medline] Soubrier, F., Martin, S., Alonso, A., Visvikis, S., Tiret, L., Matsuda, F., Lathrop, G.M. and Farrall, M. 

Phrase: "Peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "12051214."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Soubrier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "S."

Phrase: ","

Phrase: "Alonso,"

Phrase: "A.,"

Phrase: "Visvikis,"

Phrase: "S."

Phrase: ","

Phrase: "Tiret,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Matsuda,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lathrop,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Farrall,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.278: (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. 

Phrase: "(2002"

Phrase: ")"

Phrase: "High-resolution genetic mapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   812   C1283195:Mapping [Activity]

Phrase: "of the ACE-linked QTL influencing circulating ACE activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   900   C1150225:angiotensin I-converting enzyme activity [Molecular Function]
   892   C2258685:angiotensin converting enzyme activity [Molecular Function]
   864   C0243102:enzyme activity [Molecular Function]
   786   C0205177:Activity [Functional Concept]
   786   C0439167:% activity [Quantitative Concept]
   786   C0441655:Activity [Activity]
   786   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.279: Eur. 

Phrase: "Eur."
Processing 00000000.tx.280: J. 

Phrase: "J."
Processing 00000000.tx.281: Hum. 

Phrase: "Hum."
Processing 00000000.tx.282: Genet., 10, 553561.[CrossRef][ISI][Medline] Khoury, M.J., Beaty, T.H. and Cohen, B.H. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "553561."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Khoury,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Beaty,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cohen,"

Phrase: "B.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.283: (1993) Fundamentals of Genetic Epidemiology. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Fundamentals of Genetic Epidemiology."
Processing 00000000.tx.284: Oxford University Press, New York. 

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "New York."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]
Processing 00000000.tx.285: Cox, R., Bouzekri, N., Martin, S., Southam, L., Hugill, A., Golamaully, M., Cooper, R., Adeyemo, A., Soubrier, F., Ward, R. et al. 

Phrase: "Cox,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bouzekri,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "S."

Phrase: ","

Phrase: "Southam,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hugill,"

Phrase: "A.,"

Phrase: "Golamaully,"

Phrase: "M."

Phrase: ","

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Adeyemo,"

Phrase: "A.,"

Phrase: "Soubrier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "R. et al."
Processing 00000000.tx.286: (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Angiotensin-1-converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "plasma concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0683150:plasma concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "influenced by multiple ACE-linked quantitative trait nucleotides."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   797   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   756   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   738   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021966:I- [Inorganic Chemical]
   738   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0392762:Quantitative [Quantitative Concept]
   738   C0439064:Multiple [Quantitative Concept]
   738   C0599883:Trait [Organism Attribute]
   704   C1517892:Link [Intellectual Product]
   704   C1704666:Link [Intellectual Product]
Processing 00000000.tx.287: Hum. 

Phrase: "Hum."
Processing 00000000.tx.288: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.289: Genet., 11, 29692977.[Abstract/Free FullText] Pritchard, J.K. and Przeworski, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "29692977."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pritchard,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Przeworski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.290: (2001) Linkage disequilibrium in humans: models and data. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Linkage disequilibrium in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ":"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]
Processing 00000000.tx.291: Am. 

Phrase: "Am."
Processing 00000000.tx.292: J. 

Phrase: "J."
Processing 00000000.tx.293: Hum. 

Phrase: "Hum."
Processing 00000000.tx.294: Genet., 69, 114.[CrossRef][ISI][Medline] Eichner, J.E., Dunn, S.T., Perveen, G., Thompson, D.M., Stewert, K.E. and Stroehla, B.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "114."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Eichner,"

Phrase: "J.E.,"

Phrase: "Dunn,"

Phrase: "S."

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Perveen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Stewert,"

Phrase: "K.E."

Phrase: "and"

Phrase: "Stroehla,"

Phrase: "B.C."
Processing 00000000.tx.295: (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a HuGE review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]
Processing 00000000.tx.296: Am. 

Phrase: "Am."
Processing 00000000.tx.297: J. 

Phrase: "J."
Processing 00000000.tx.298: Epidemiol., 155, 487495.[Abstract/Free FullText] Galasko, D., Chang L., Motter, R., Clark, C.M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I. et al. 

Phrase: "Epidemiol.,"

Phrase: "155,"

Phrase: "487495."

Phrase: "[Abstract/Free FullText"

Phrase: "] Galasko,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Chang L., Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Kaye,"

Phrase: "J.,"

Phrase: "Knopman,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Thomas,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kholodenko,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Schenk,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Lieberburg,"

Phrase: "I. et al."
Processing 00000000.tx.299: (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. 

Phrase: "(1998"

Phrase: ")"

Phrase: "High cerebrospinal fluid tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   738   C0441889:Levels [Qualitative Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "relation to apolipoprotein E genotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]
Processing 00000000.tx.300: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.301: Neurol., 55, 937945.[Abstract/Free FullText] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "937945."

Phrase: "[Abstract/Free FullText"

Phrase: "] McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of department of health and human services task force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: Neurology, 34, 939944.[Abstract] Mirra, S.S., Heyman, A. and McKeel, D. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mirra,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Heyman,"

Phrase: "A."

Phrase: "and"

Phrase: "McKeel,"

Phrase: "D."
Processing 00000000.tx.304: (1991) The consortium to establish a registry for Alzheimer's Disease (CERAD). 

Phrase: "(1991"

Phrase: ")"

Phrase: "The consortium to establish a registry for Alzheimer's Disease (CERAD)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.305: Part II. 

Phrase: "Part II."
Processing 00000000.tx.306: Standardization of the neuropathologic assessment of Alzheimer's disease. 

Phrase: "Standardization of the neuropathologic assessment of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038136:Standardization [Research Activity]
Processing 00000000.tx.307: Neurology, 41, 479486.[Abstract] Folstein, M., Folstein, S. and McHugh, P. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "41,"

Phrase: "479486."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Folstein,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "McHugh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.308: (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Mini-Mental State"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0278060:Mental state [Finding]
   827   C0229992:mental [Mental Process]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   743 E C0229993:Psychic [Functional Concept]
   727 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C0042241:DIAPHRAGM [Medical Device]
   727 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C1705367:Diaphragm [Medical Device]
   716 E C0086045:mindfulness [Mental Process]
   716 E C3542996:Mindfulness [Mental Process]

Phrase: ":"

Phrase: "a practical method for grading"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "the cognitive state of patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0683521:Patient State [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1516691:Cognitive [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "for the clinician."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871685:Clinician [Professional or Occupational Group]
  1000   C1550470:clinician [Idea or Concept]
Processing 00000000.tx.309: J. 

Phrase: "J."
Processing 00000000.tx.310: Psychiatr. 

Phrase: "Psychiatr."
Processing 00000000.tx.311: Res., 12, 189198.[CrossRef][ISI][Medline] Kehoe, P.G., Russ, C., McIlory, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B. et al. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "12,"

Phrase: "189198."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kehoe,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Russ,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McIlory,"

Phrase: "S."

Phrase: ","

Phrase: "Williams,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Holmes,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Liolitsa,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Vahidassr,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Powell,"

Phrase: "J.,"

Phrase: "McGleenon,"

Phrase: "B. et al."
Processing 00000000.tx.312: (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Variation in DCP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "associated with susceptibility"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.313: Nat. 

Phrase: "Nat."
Processing 00000000.tx.314: Genet., 21, 7172.[CrossRef][ISI][Medline] Reuterwall, C., Hallqvist, J., Ahlbom, A., de Faire, U., Diderichsen, F., Hogstedt, C., Pershagen, G., Theorell, T., Wiman, B. and Wolk, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "21,"

Phrase: "7172."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reuterwall,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hallqvist,"

Phrase: "J.,"

Phrase: "Ahlbom,"

Phrase: "A.,"

Phrase: "de Faire,"

Phrase: "U.,"

Phrase: "Diderichsen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hogstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pershagen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Theorell,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wiman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wolk,"

Phrase: "A."
Processing 00000000.tx.315: (1999) Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study, The SHEEP study group. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Higher relative,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "but"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "absolute risks of myocardial infarction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1519101:absolute risk [Quantitative Concept]
   760   C0035647:Risks [Qualitative Concept]
   760   C0205344:Absolute [Qualitative Concept]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "than"

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: ":"

Phrase: "analysis of some major risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0085801:analysis factors [Quantitative Concept]
   783   C0814767:risk analysis [Qualitative Concept]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in the SHEEP study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0489835:Heart study [Diagnostic Procedure]
   817   C0002783:Epidemiologic Study [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: "The SHEEP study group."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   858   C0489835:Heart study [Diagnostic Procedure]
   803   C0002783:Epidemiologic Study [Research Activity]
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.316: J. 

Phrase: "J."
Processing 00000000.tx.317: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.318: Med., 246, 161174.[CrossRef][ISI][Medline] Howell, W.M., Jobs, M. and Brookes, A.J. 

Phrase: "Med.,"

Phrase: "246,"

Phrase: "161174."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Howell,"

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Jobs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028811:jobs [Occupation or Discipline]
   966 E C2826594:Job [Machine Activity]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Brookes,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.319: (2002) iFRET: an improved fluorescence system for DNA-melting analysis. 

Phrase: "(2002"

Phrase: ")"

Phrase: "iFRET"

Phrase: ":"

Phrase: "an improved fluorescence system for DNA-melting analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0039152:analysis system [Occupational Activity]
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
Processing 00000000.tx.320: Genome Res., 12, 14011407.[Abstract/Free FullText] Crawford, F., Abdullah, L., Schinka, J., Suo, Z., Gold, M., Duara, R. and Mullan, M. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "12,"

Phrase: "14011407."

Phrase: "[Abstract/Free FullText"

Phrase: "] Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Abdullah,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Schinka,"

Phrase: "J.,"

Phrase: "Suo,"

Phrase: "Z.,"

Phrase: "Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: "M."

Phrase: ","

Phrase: "Duara,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mullan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: (2000) Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Gender-specific association of the angiotensin converting enzyme gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.322: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.323: Lett., 280, 215219.[CrossRef][ISI][Medline] Farrer, L.A., Sherbatich, T., Keryanov, S.A., Korovaitseva, G.I., Rogaeva, E.A., Petruk, S., Premkumar, S., Moliaka, Y., Song, Y.Q., Pei, Y. et al. 

Phrase: "Lett.,"

Phrase: "280,"

Phrase: "215219."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer,"

Phrase: "L.A.,"

Phrase: "Sherbatich,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Keryanov,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Korovaitseva,"

Phrase: "G.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Petruk,"

Phrase: "S."

Phrase: ","

Phrase: "Premkumar,"

Phrase: "S."

Phrase: ","

Phrase: "Moliaka,"

Phrase: "Y.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "Y.Q., Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0814202:PEI [Intellectual Product]
   827   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "Y. et al."
Processing 00000000.tx.324: (2000) Association between angiotensin-converting enzyme and Alzheimer disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association between angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.325: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.326: Neurol., 57, 210214.[Abstract/Free FullText] Yang, J.D., Feng, G., Zhang, J., Lin, Z.X., Shen, T., Breen, G., St Clair. 

Phrase: "Neurol.,"

Phrase: "57,"

Phrase: "210214."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "J.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Feng,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Z.X.,"

Phrase: "Shen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Breen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "St Clair."
Processing 00000000.tx.327: D. and He, L. 

Phrase: "D."

Phrase: "and"

Phrase: "He,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.328: (2000) Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han chinese. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association between angiotensin-converting enzyme gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "late onset Alzheimer's disease in Han chinese."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   800   C0814122:late disease onset [Finding]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.329: Neuroscience, 295, 4144. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "295,"

Phrase: "4144."
Processing 00000000.tx.330: Cheng, C.Y., Hong, C.J., Liu, H.C., Liu, T.Y. and Tsai, S.J. 

Phrase: "Cheng,"

Phrase: "C.Y.,"

Phrase: "Hong,"

Phrase: "C.J.,"

Phrase: "Liu,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Liu,"

Phrase: "T.Y."

Phrase: "and"

Phrase: "Tsai,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.331: (2002) Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Study of the association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C2603343:Study [Research Activity]

Phrase: "between Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "angiotensin-converting enzyme gene polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0678951:gene polymorphism [Genetic Function]
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA from lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.332: Eur. 

Phrase: "Eur."
Processing 00000000.tx.333: Neurol., 47, 2629.[CrossRef][ISI][Medline] Lendon, C.L., Thaker, U., Harris, J.M., McDonagh, A.M., Lambert, J.C., Chartier-Harlin, M.C., Iwatsubo, T., Pickering-Brown, S.M. and Mann, D.M. 

Phrase: "Neurol.,"

Phrase: "47,"

Phrase: "2629."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lendon,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Thaker,"

Phrase: "U.,"

Phrase: "Harris,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "McDonagh,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Mann,"

Phrase: "D.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.334: (2002) The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   795   C0021107:Insertion [Therapeutic or Preventive Procedure]
   795   C0032529:Polymorphism [Genetic Function]
   795   C0441587:Insertion [Health Care Activity]
   795   C1442161:Deletion [Cell or Molecular Dysfunction]
   795   C1511760:Deletion [Genetic Function]
   795   C1512796:Insertion [Genetic Function]
   795   C1880274:Deletion [Activity]
   795   C1882417:Polymorphism [Qualitative Concept]
   795   C1883719:Insertion [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the extent of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "or"

Phrase: "tau pathology in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "with sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.335: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.336: Lett., 328, 314318.[CrossRef][ISI][Medline] Buss, S., Muller-Thomsen, T., Hock, C., Alberici, A., Binetti, G., Nitsch, R.M., Gal, A. and Finckh, U. 

Phrase: "Lett.,"

Phrase: "328,"

Phrase: "314318."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Buss,"

Phrase: "S."

Phrase: ","

Phrase: "Muller-Thomsen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Alberici,"

Phrase: "A.,"

Phrase: "Binetti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Gal,"

Phrase: "A."

Phrase: "and"

Phrase: "Finckh,"

Phrase: "U."
Processing 00000000.tx.337: (2002) No association between DCP1 genotype and late-onset Alzheimer disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "No association between DCP1 genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.338: Am. 

Phrase: "Am."
Processing 00000000.tx.339: J. 

Phrase: "J."
Processing 00000000.tx.340: Med. 

Phrase: "Med."
Processing 00000000.tx.341: Genet., 114, 440445.[CrossRef][ISI][Medline] Myllykangas, L., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Tienari, P., Niinisto, L., Kontula, K., Hardy, J., Haltia, M. and Perez-Tur, J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "114,"

Phrase: "440445."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myllykangas,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Polvikoski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sulkava,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoniemi,"

Phrase: "A.,"

Phrase: "Tienari,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Niinisto,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kontula,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Haltia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Perez-Tur,"

Phrase: "J."
Processing 00000000.tx.342: (2000) Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cardiovascular risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0850624:cardiovascular risk factor [Disease or Syndrome]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a genetic association study in a population"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   800   C1517511:Genetic Population Study [Research Activity]
   774   C0681876:Population Study [Research Activity]
   774   C2348561:Study Population [Population Group]
   774   C2827447:Genetic Study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "85"

Phrase: "or"

Phrase: "over."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]
Processing 00000000.tx.343: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.344: Lett., 292, 195198.[CrossRef][ISI][Medline] Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Urakami, K. and Shoji, M. 

Phrase: "Lett.,"

Phrase: "292,"

Phrase: "195198."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "J.,"

Phrase: "Miyatake,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Aizu,"

Phrase: "Y.,"

Phrase: "Nakagawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "S."

Phrase: ","

Phrase: "Tamaoka,"

Phrase: "A.,"

Phrase: "Takahash,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Urakami,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Shoji,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: (1999) Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Angiotensin-converting enzyme genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017431:Genotype [Organism Attribute]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "is"

Phrase: "associated with Alzheimer disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in the Japanese population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.346: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.347: Lett., 277, 6567.[CrossRef][ISI][Medline] Alvarez, R., Alvarez, V., Lahoz, C.H., Martinez, C., Pena, J., Sanchez, J.M., Guisasola, L.M., Salas-Puig, J., Moris, G., Vidal, J.A. et al. 

Phrase: "Lett.,"

Phrase: "277,"

Phrase: "6567."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alvarez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alvarez,"

Phrase: "V.,"

Phrase: "Lahoz,"

Phrase: "C.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pena,"

Phrase: "J.,"

Phrase: "Sanchez,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Guisasola,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salas-Puig,"

Phrase: "J.,"

Phrase: "Moris,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "J."

Phrase: "A. et al."
Processing 00000000.tx.348: (1999) Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Angiotensin converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "endothelial nitric oxide synthase DNA polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0032529:polymorphisms [Genetic Function]
   766 E C1882417:Polymorphism [Qualitative Concept]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "and"

Phrase: "late onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.349: J. 

Phrase: "J."
Processing 00000000.tx.350: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.351: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.352: Psychiat., 67, 733736.[Abstract/Free FullText] Perry, R.T., Collins, J.S., Harrell, L.E., Acton, R.T. and Go, R.C. 

Phrase: "Psychiat.,"

Phrase: "67,"

Phrase: "733736."

Phrase: "[Abstract/Free FullText"

Phrase: "] Perry,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "J.S.,"

Phrase: "Harrell,"

Phrase: "L.E.,"

Phrase: "Acton,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.353: (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Investigation of association of 13 polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "in eight genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "in southeastern African American Alzheimer disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "as"

Phrase: "compared to age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.354: Am. 

Phrase: "Am."
Processing 00000000.tx.355: J. 

Phrase: "J."
Processing 00000000.tx.356: Med. 

Phrase: "Med."
Processing 00000000.tx.357: Genet., 105, 332342.[CrossRef][ISI][Medline] Mattila, K.M., Rinne, J.O., Roytta, M., Laippala, P., Pietila, T., Kalimo, H., Koivula, T., Frey, H. and Lehtimaki, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "105,"

Phrase: "332342."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattila,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rinne,"

Phrase: "J.O.,"

Phrase: "Roytta,"

Phrase: "M."

Phrase: ","

Phrase: "Laippala,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pietila,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kalimo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Koivula,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Frey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lehtimaki,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.358: (2000) Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Dipeptidyl carboxypeptidase 1 (DCP1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022709:Dipeptidyl Carboxypeptidase 1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1413931:DIPEPTIDYL CARBOXYPEPTIDASE 1 [Gene or Genome]
   901   C0058360:dipeptidyl carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3265462:Carboxypeptidase [Pharmacologic Substance]

Phrase: "and"

Phrase: "butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596610:gene interaction [Genetic Function]
   708   C1704675:Interaction [Functional Concept]

Phrase: "as risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with coexisting Alzheimer pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.359: J. 

Phrase: "J."
Processing 00000000.tx.360: Med. 

Phrase: "Med."
Processing 00000000.tx.361: Genet., 37, 766770.[Abstract/Free FullText] Chapman, J., Wang, N., Treves, T.A., Korczyn, A.D. and Bornstein, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "766770."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chapman,"

Phrase: "J.,"

Phrase: "Wang,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Treves,"

Phrase: "T.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Korczyn,"

Phrase: "A.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "Bornstein,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.362: (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "MTHFR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066357:MTHFR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0268615:MTHFR [Disease or Syndrome]
  1000   C0919427:MTHFR [Gene or Genome]

Phrase: "factor V Leiden,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0380964:factor V Leiden [Amino Acid, Peptide, or Protein]
  1000   C0584960:Factor V Leiden [Disease or Syndrome]
  1000   C2681926:FACTOR V LEIDEN [Gene or Genome]
  1000   C3542419:Factor V Leiden [Laboratory Procedure]
   734   C0015498:Factor V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3274393:Factor V [Laboratory Procedure]

Phrase: "and"

Phrase: "APOE polymorphisms in patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.363: Stroke, 29, 14011404.[Abstract/Free FullText] Scacchi, R., De Bernardini, L., Mantuano, E., Vilardo, T., Donini, L.M., Ruggeri, M., Gemma, A.T., Pascone, R. and Corbo, R.M. 

Phrase: "Stroke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "29,"

Phrase: "14011404."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scacchi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "De Bernardini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mantuano,"

Phrase: "E.,"

Phrase: "Vilardo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Donini,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Ruggeri,"

Phrase: "M."

Phrase: ","

Phrase: "Gemma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1899593:Gemma [Eukaryote]
  1000   C2700462:Gemma [Plant]

Phrase: "A.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "Pascone,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Corbo,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: (1998) DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "DNA polymorphisms of apolipoprotein B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "angiotensin I-converting enzyme genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "and"

Phrase: "relationships with lipid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "in Italian patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.365: Dement. 

Phrase: "Dement."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0860630:dement [Mental or Behavioral Dysfunction]
   900 E C0011265:dementia [Mental or Behavioral Dysfunction]
   900 E C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.366: Geriatr. 

Phrase: "Geriatr."
Processing 00000000.tx.367: Cogn. 

Phrase: "Cogn."
Processing 00000000.tx.368: Disord., 9, 186190.[CrossRef][ISI][Medline] Palumbo, B., Cadini, D., Nocentini, G., Filipponi, E., Fravolini, M.L. and Senin, U. 

Phrase: "Disord.,"

Phrase: "9,"

Phrase: "186190."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palumbo,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cadini,"

Phrase: "D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "Nocentini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Filipponi,"

Phrase: "E.,"

Phrase: "Fravolini,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Senin,"

Phrase: "U."
Processing 00000000.tx.369: (1999) Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Angiotensin converting enzyme deletion allele in different kinds of dementia disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.370: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.371: Lett., 267, 97100.[CrossRef][ISI][Medline] Zuliani, G., Ble, A., Zanca, R., Munari, M.R., Zurlo, A., Vavalle, C., Atti, A.R. and Fellin, R. 

Phrase: "Lett.,"

Phrase: "267,"

Phrase: "97100."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zuliani,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ble,"

Phrase: "A.,"

Phrase: "Zanca,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Munari,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zurlo,"

Phrase: "A.,"

Phrase: "Vavalle,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Atti,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Fellin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.372: (2001) Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Genetic polymorphisms in older subjects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.373: Acta Neurol. 

Phrase: "Acta Neurol."
Processing 00000000.tx.374: Scand., 103, 304308.[CrossRef][ISI][Medline] Isbir, T., Agachan, B., Yilmaz, H. and Aydin, M. 

Phrase: "Scand.,"

Phrase: "103,"

Phrase: "304308."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Isbir,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agachan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yilmaz,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Aydin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: (2000) Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Angiotensin converting enzyme gene polymorphism in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.376: Cell Biochem. 

Phrase: "Cell Biochem."
Processing 00000000.tx.377: Funct., 18, 141142.[CrossRef][ISI][Medline]

Phrase: "Funct.,"

Phrase: "18,"

Phrase: "141142."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

